Podcasts about Moderna

Share on
Share on Facebook
Share on Twitter
Share on Reddit
Copy link to clipboard

American biotechnology company

  • 3,727PODCASTS
  • 8,646EPISODES
  • 32mAVG DURATION
  • 9DAILY NEW EPISODES
  • Jan 25, 2022LATEST
Moderna

POPULARITY

20122013201420152016201720182019202020212022


Best podcasts about Moderna

Show all podcasts related to moderna

Latest podcast episodes about Moderna

Heiko Thieme Börsen Club
Heiko Thieme: "Crash, Korrektur oder Baisse? Alles! Und das sind erstklassige Kaufchancen"

Heiko Thieme Börsen Club

Play Episode Listen Later Jan 25, 2022 13:23


Die Gefahr eines Krieges in der Ukraine und damit mitten in Europa ist so groß wie seit Jahrzehnten nicht mehr. Das erkennen auch die Anleger. Die einzige Hoffnung dabei ist, dass alle Beteiligten wissen, dass ein Krieg verheerend wäre und unbedingt vermieden werden muss. Dieses Damoklesschwert, verbunden mit dem Schwenk in der Geldpolitik der US-Notenbank Fed hat zu einem fast schon brutalen Ausverkauf an den Märkten geführt. Doch im Gegenzug haben die Profis nicht nur die Chancen erkannt, sondern auch gleich genutzt. Auf den Crash folgte also postwendend eine der stärksten Erholungen seit Jahren. Mit welcher Strategie Anleger jetzt agieren und auf welche Werte, Indizes oder Aktien sie setzen, erfahren Sie exklusiv in dieser Clubausgabe 04/22. Behandelte Aktien u.a.: Siemens Energy, Volkswagen, Novavax, Moderna, Biontech, Baidu, Alibaba, Continental, Philips, TeamViewer, Zoom, Dow Jones, DAX, Nikkei. Gekürzte Clubausgabe! Gesamtlänge für Clubmitglieder: 65 Minuten. Zur aktuellen Ausgabe: https://go.brn-ag.de/163 . Werden sie Clubmitglied: https://www.heiko-thieme.club/anmeldung-monatsabo/

Alles auf Aktien
Psychofalle Börse und neue Chancen bei Impfstoffaktien

Alles auf Aktien

Play Episode Listen Later Jan 25, 2022 17:30


In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über eine kräftige Kurserholung an der Wall Street, Rekordumsätze bei Ark und gute Zahlen bei IBM. Außerdem geht es um Tesla, AirBnB, Netflix, Moderna, Biontech, Datadog, Atlassian, Splunk, Bitcoin, Delivery Hero, HelloFresh, Deutsche Bank, Valneva, Novavax, Curevac, Pfizer, GSK, Bayer, Basisinvestments: iShares Core MSCI World (WKN: A0HGV0), Vanguard ESG Global All Cap (WKN: A2QL8U), SPDR MSCI All Country World IMI (WKN: A1JJTD), Lyxor MSCI ACWI (WKN: LYX00C), iShares Nasdaq US Biotechnology ETF (WKN A2DWAW). "Alles auf Aktien" ist der tägliche Börsen-Shot aus der WELT-Wirtschaftsredaktion. Die Wirtschafts- und Finanzjournalisten Holger Zschäpitz, Anja Ettel, Philipp Vetter, Daniel Eckert und Nando Sommerfeldt diskutieren im Wechsel über die wichtigsten News an den Märkten und das Finanzthema des Tages. Außerdem gibt es jeden Tag eine Inspiration, die das Leben leichter machen soll. In nur zehn Minuten geht es um alles, was man aktuell über Aktien, ETFs, Fonds und erfolgreiche Geldanlage wissen sollte. Für erfahrene Anleger und Neueinsteiger. Montag bis Freitag, ab 5 Uhr morgens. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++Werbung+++ Hier geht's zur App: Scalable Capital ist der Broker mit Flatrate. Unbegrenzt Aktien traden und alle ETFs kostenlos besparen – für nur 2,99 € im Monat, ohne weitere Kosten. Und jetzt ab aufs Parkett, die Scalable App downloaden und loslegen. Hier geht's zur App: https://bit.ly/3abrHQm

John and Ken on Demand
John & Ken Show Hour 2 (01/21)

John and Ken on Demand

Play Episode Listen Later Jan 22, 2022 31:40


The CDC put out several studies saying if you got the Pfizer or Moderna vaccines they will protect you from hospitalization due to the omicron variant of COVID-19. California may try a basic income for college students. A murder charge has been filed against the suspect who allegedly killed Brianna Kupfer.

Secure Freedom Radio Podcast
With Dr. Peter McCullough

Secure Freedom Radio Podcast

Play Episode Listen Later Jan 21, 2022 52:57


DR. PETER MCCULLOUGH, Board Certificed Cardiovascular Diseases and Clinical Lipidology Practioner, Former Chief Academic and Scientific Officer, St. John Providence Health System, President, Cardioernal Society of America, @P_McCulloughMD Where do we go from the Omicron variant? Dr. Peter McCullough makes the case against over testing in the United States: “We're not getting any clarity on what's going on in the pandemic…We certainly can't rely on any reports about hospitalization” Dr. McCullough talks about the medical community's initial disavowal of therapeutic treatments for COVID-19 Dr. McCullough's advice on how to proceed through the pandemic: “I think at this point in time, we go ahead and drop all the vaccine mandates. We can make things very easy for the Supreme Court and the Biden administration. And then we pull the vaccines off the market – Pfizer, J&J and Moderna. Pull them….Do a review on safety. Figure out what went wrong: Why did they fail against the variants?"

The American Mind
Vaximum Overdrive | The Roundtable Ep. 103

The American Mind

Play Episode Listen Later Jan 21, 2022 52:53


At the World Economic Forum, led by International Supervillain Klaus Schwab, Moderna has announced its plans to get absolutely everyone vaccinated against everything (or else) with its new omni-jab. While the big pharma CEOs bathe in their piles of cash, Biden is trying, poorly, to brag about his supposed “accomplishments”—all while skirting foreign policy issues like Russia's moves to annex Ukraine. Our editors have thoughts.

Markley, van Camp and Robbins
Markley, van Camp and Robbins | January 20, 2022

Markley, van Camp and Robbins

Play Episode Listen Later Jan 20, 2022 116:12


MVC&R were monitoring President Joe Biden's speech on Wednesday, and the President fumbled his way through, while displaying uncertainty when it comes to Russia in Ukraine. Dana Bash is clarifying election comments President Biden made, and Vice President Kamala Harris says world leaders are worried about us. The Therapeutic Goods Administration has confirmed the first cases of myocarditis and pericarditis after Pfizer and Moderna boosters, and Alec Baldwin is being sued by the family of a Marine killed during the Afghanistan pullout. Oscar Mayer is selling a new bologna-inspired beauty mask, and NBC sports announcers will not be traveling to China to call the Olympics.

Roach Clip Podcast

Tolo has an adverse reaction on his second dose of the Moderna vaccine, do you trust food delivery services?, Roblox is breaking records, pineapple on pizza, Franco finally becomes a Cobra Kai aficionado, and fumes that cause birth defects throughout history. --- Support this podcast: https://anchor.fm/roachclippodcast/support

Kevin Kietzman Has Issues
Saban Loses Again, 4th Shot is Dud, Mahomes Smashing Records, Mark Smith Taunts Texas

Kevin Kietzman Has Issues

Play Episode Listen Later Jan 19, 2022 52:25


   Fresh off his loss in the national title game, Alabama coach Nick Saban loses again as he signs a letter in support of something called the "freedom to vote" act.  This has a million holes in it including Saban wanting elections to be as good as referees.  What?  You have to hear this complete story.    Officials in Israel and South Africa say the 4th shot is of no use to anyone.  Don't believe them?  Follow the hedge fund guys as Moderna and Biontech stocks are getting crushed.    Patrick Mahomes has 22 td passes in the playoffs and he's just 26 years old.  Wait until you hear the list of Hall of Fame quarterbacks that already beats.     And a rare night as KU, KSU and MU all win in hoops.  Former Tiger turned Wildcat Mark Smith grabs headlines at Texas for doing the Horns Down sign... we'll tell you why he says it's just payback.

WHOOP Podcast
WHOOP unveils new research on Omicron variant of COVID-19

WHOOP Podcast

Play Episode Listen Later Jan 19, 2022 28:25


Since the beginning of the pandemic, WHOOP has been conducting research to better understand how COVID can affect sleep and recovery, what physiological response vaccines produce, and perhaps most importantly, how COVID affects respiratory rate. Our latest WHOOP research shows that with the Omicron variant, like previous strains of the virus, COVID-19 infections often coincide with an increase in respiratory rate. WHOOP VP of Data Science and Research Emily Capodilupo returns to the podcast to detail our findings (3:34), why respiratory rate is so important to track (5:31), how men and women may see different data with Omicron (8:30), why you could see a respiratory rate dip after a spike (9:13), Omicron and the vaccines (14:23), factors that can increase your respiratory rate (18:34), the latest information on testing (20:07), and an update on WHOOP vaccine research (24:35). Support the show (http://whoop.com)

MoneyBall Medicine
What Exponential Change Really Means in Healthcare, with Azeem Azhar

MoneyBall Medicine

Play Episode Listen Later Jan 18, 2022 57:25


As we say here on The Harry Glorikian Show, technology is changing everything about healthcare works—and the reason we keep talking about it month after month is that the changes are coming much faster than they ever did in the past. Each leap in innovation enables an even bigger leap just one step down the road. Another way of saying this is that technological change today feels exponential. And there's nobody who can explain exponential change better than today's guest, Azeem Azhar.Azeem produces a widely followed newsletter about technology called Exponential View. And last year he published a book called The Exponential Age: How Accelerating Technology is Transforming Business, Politics, and Society. He has spent his whole career as an entrepreneur, investor, and writer trying to help people understand what's driving the acceleration of technology — and how we can get better at adapting to it. Azeem argues that most of our social, business, and political institutions evolved for a period of much slower change—so we need to think about how to adapt these institutions to be more nimble. If we do that right, then maybe we can apply the enormous potential of all these new technologies, from computing to genomics, in ways that improve life for everyone.Please rate and review The Harry Glorikian Show on Apple Podcasts! Here's how to do that from an iPhone, iPad, or iPod touch:1. Open the Podcasts app on your iPhone, iPad, or Mac. 2. Navigate to The Harry Glorikian Show podcast. You can find it by searching for it or selecting it from your library. Just note that you'll have to go to the series page which shows all the episodes, not just the page for a single episode.3. Scroll down to find the subhead titled "Ratings & Reviews."4. Under one of the highlighted reviews, select "Write a Review."5. Next, select a star rating at the top — you have the option of choosing between one and five stars. 6. Using the text box at the top, write a title for your review. Then, in the lower text box, write your review. Your review can be up to 300 words long.7. Once you've finished, select "Send" or "Save" in the top-right corner. 8. If you've never left a podcast review before, enter a nickname. Your nickname will be displayed next to any reviews you leave from here on out. 9. After selecting a nickname, tap OK. Your review may not be immediately visible.That's it! Thanks so much.Full TranscriptHarry Glorikian: Hello. I'm Harry Glorikian. Welcome to The Harry Glorikian Show, the interview podcast that explores how technology is changing everything we know about healthcare.Artificial intelligence. Big data. Predictive analytics. In fields like these, breakthroughs are happening way faster than most people realize. If you want to be proactive about your own health and the health of your loved ones, you'll need to learn everything you can about how medicine is changing and how you can take advantage of all the new options.Explaining this approaching world is the mission of my new book, The Future You. And it's also our theme here on the show, where we bring you conversations with the innovators, caregivers, and patient advocates who are transforming the healthcare system and working to push it in positive directions.So, when you step back and think about it, why is it that people like me write books or make podcasts about technology and healthcare?Well, like I just said, it's because tech is changing everything about healthcare works—and the changes are coming much faster than they ever did in the past.In fact, the change feels like it's accelerating. Each leap in innovation enables an even bigger leap just one step down the road.Another way of saying this is that technological change today feels exponential.And there's nobody who can explain exponential change better than today's guest, Azeem Azhar.Azeem produces a widely followed newsletter about technology called Exponential View.And last year he published a book called The Exponential Age: How Accelerating Technology is Transforming Business, Politics, and Society.He has spent his whole career as an entrepreneur, investor, and writer trying to help people understand what's driving the acceleration of technology — and how we can get better at adapting to it.Azeem argues that most of our social, business, and political institutions evolved for a period of much slower change. So we need to think about how to adapt these institutions to be more nimble.If we do that right, then maybe we can apply the enormous potential of all these new technologies, from computing to genomics, in ways that improve life for everyone.Azeem and I focus on different corners of the innovation world. But our ideas about things like the power of data are very much in sync. So this was a really fun conversation. Here's Azeem Azhar.Harry Glorikian: Azeem, welcome to the show.Azeem Azhar: Harry, what a pleasure to be here.Harry Glorikian: I definitely want to give you a chance to sort of talk about your work and your background, so we really get a sense of who you are. But I'd first like to ask a couple of, you know, big picture questions to set the stage for everybody who's listening. You like this, your word and you use it, "exponential," in your branding and almost everything you're doing across your platform, which is what we're going to talk about. But just for people who don't, aren't maybe familiar with that word exponential. What does that word mean to you? Why do you think that that's the right word, word to explain how technology and markets are evolving today?Azeem Azhar: Such a great question. I love the way you started with the easy questions. I'm just kidding because it's it's hard. It's hard to summarize short, but in a brief brief statement. So, you know, exponential is this idea that comes out of math. It is the idea that something grows by a fixed proportion in any given time period. An interest-bearing savings account, 3 percent growth or in the old days, we'd get 3 percent per annum, three percent compounded. And compound interest is really powerful. It's what your mom and your dad told you. Start saving early so that when you're a bit older, you'll have a huge nest egg, and it never made sense to us. And the idea behind an exponential is that these are processes which, you know, grow by that certain fixed percentage every year. And so the amount they grow grows every time. It's not like going from the age of 12 to 13 to 14 to 15 were actually proportionately—you get less older every year because when you go from 15 to 16, you get older by one fifteenth of your previous age. And when you go from 50 to fifty one, it's by one 50th, which is a smaller proportion. Someone who is growing in age exponentially would be growing by, say, 10 percent every year. So you go from 10 to 11 and that's by one year. From 20, you go to 22, two years. From 30 to 33. So that's the idea of an exponential process. It's kind of compound interest. But why I use the phrase today to describe what's going on in the economy and in the technologies that drive the economy, is that many of the key technologies that we currently rely on and will rely on as they replace old industrial processes are improving at exponential rates on a price-performance basis.Azeem Azhar: That means that every year you get more of them for less, or every year what you got for the the same dollar you get much more. And I specifically use a threshold, and that threshold is to say essentially it's an exponential technology if it's improving by double digits, 10 percent or more every year on a compounding basis for decades. And many of the technologies that I look at increased by improve by 30, 40, 50, 60 percent or more every year, which is pretty remarkable. The reverse of that, of course, is deflation, right? These capabilities are getting much cheaper. And I think the reason that's important and the reason it describes the heartbeat of our economies is that we're at a point in development of, you know, sort of economic and technological development where these improvements can be felt. They're viscerally felt across a business cycle. Across a few years, in fact. And that isn't something that we have reliably and regularly seen in any previous point in history. The idea that this pace of change can be as fast as it as it is. And on the cover of my book The Exponential Age, which I'm holding up to you, Harry. The thing about the curve is is that it starts off really flat and a little bit boring, and you would trade that curve for a nice, straight, sharp line at 45 degrees. And then there's an inflection point when it goes suddenly goes kind of crazy and out of control. And my argument is that we are now past that inflection point and we are in that that sort of vertical moment and we're going to have to contend with it.Harry Glorikian: Yeah, I mean, we are mentally aligned. And I try to talk to people about this. I mean, when we were doing the genome project that Applied Biosystems, you know, when we had finished, I think it was 2 percent or 4 percent of the genome, everybody's like, Oh, you have like ninety something [to go], and they couldn't see the exponential curve. And then we were done like five years later. And so it's it's this inability of the human mind. You know, it's really not designed to do that, but we're not designed to see exponential shift. We're sort of looking around that corner from an evolutionary perspective to see what's happening. But, you know? Exponential growth is not a new concept, if you think about, you know, really, I think the person that brought it to the forefront was Gordon Moore, right? With, you know, how semiconductor chips were going to keep doubling every two years and cost was going to stay flat. And you know, how do you see it playing out? Today, what is so different right now, or say, in the past two, three, four, five years. What you can see going forward that. May not have been as obvious 10 or 15 years ago.Azeem Azhar: I mean, it is an idea that's been around with us for a long time. You know, arguably Thomas Malthus, the British scholar in the 18th century who worried about the exponential growth of the population destroying the land's carrying capacity and ability to produce crops. And of course, we have the sort of ancient Persian and Hindu stories about the vizier and the chessboard, who, you know, puts a grain of rice and doubles on each square and doubles at each time. So it's an idea that's been around for a while. The thing that I think has happened is that it's back to its back to that point, the kink, the inflection in the curve. The point at which in the story of the chess, the king gets so angry with his vizier that he chops off his head. The point with the semiconductors, where the chips get so powerful and so cheap that computing is everything, and then every way in which we live our lives is mediated through these devices. And that wasn't always the way. I mean, you and I, Harry, are men of a certain age, and we remember posting letters and receiving mail through the letterbox in the morning. And there was then, some 15 years later, there were, or 20 years later, there was a fax, right? I mean, that's what it looked like.Azeem Azhar: And the thing that's different now from the time of Gordon Moore is that that what he predicted and sort of saw out as his clock speed, turns out to be a process that occurs in many, many different technology fields, not just in computing. And the one that you talked about as well, genome sequencing. And in other areas like renewable energy. And so it becomes a little bit like...the clock speed of this modern economy. But the second thing that is really important is to ask that question: Where is the bend in the curve? And the math purists amongst your listeners will know that an exponential curve has no bend. It depends on where you zoom in. Whatever however you zoom, when you're really close up, you're really far away. You'll always see a band and it will always be in a different place. But the bend that we see today is the moment where we feel there is a new world now. Not an old world. There are things that generally behave differently, that what happens to these things that are connected to exponential processes are not kind of geeks and computer enthusiasts are in Silicon Valley building. They're happening all over the world. And for me, that turning point happens some point between 2011, 2012 and 2015, 2016. Because in 2009, America's largest companies wereAzeem Azhar: not in this order, Exxon, Phillips, Wal-Mart, Conoco... Sorry, Exxon Mobil, Wal-Mart, ConocoPhillips, Chevron, General Motors, General Electric, Ford, AT&T, Valero. What do all of them have in common? They are all old companies are all built on three technologies that emerged in the late 19th century. The car or the internal combustion engine, the telephone and electricity. And with the exception of Wal-Mart, every one of those big companies was founded between about 1870 and sort of 1915. And Wal-Mart is dependent on the car because you needed suburbs and you needed large cars with big trunks to haul away 40 rolls of toilet paper. So, so and that was a century long shift. And then if you look out four years after 2009, America's largest firms, in fact, the world's largest firms are all Exponential Age firms like the Tencent and the Facebooks of this world. But it's not just that at that period of time. That's the moment where solar power became for generating electricity became cheaper than generating electricity from oil or gas in in most of the world. It's the point at which the price to sequence the human genome, which you know is so much better than I do, diminished below $1000 per sequence. So all these things came together and they presented a new way of doing things, which I call the Exponential Age.Harry Glorikian: Yeah, in my last book. I, you know, I do state that the difference between evolution and revolution is time, right? If you wait long enough, things happen evolutionarily, but at the speed that things are changing, it feels revolutionary and in how it's affecting everybody. So let's rewind and talk about your background. You've been active as a business columnist, as a journalist, a startup founder, a CEO, a leader of corporate innovation, incubators at Reuters and a venture capital partner. Lately you've built what eems like a very busy career around books and talks and podcasts and all around this theme of accelerating technologies, I'd love to hear how you how you first got interested in all these themes about technological change. You know, how society can manage this change? I know you were in Oxford. You got your master's degree in the famous PPE program. The politics, philosophy and economics. You know, was it soon after that that you went down this road? Or is Oxford where it all started?Azeem Azhar: It started well before then in, in a weird way. So, so you know, my interest really is between sits between technology and an economic institutions and society. And I, I was born, like most of us are, to two parents, and my parents were working in in Zambia in the early 70s, and my dad was working on helping this newly independent country develop economic institutions. It didn't have them and it needed them to go through that sort of good institutions, make for healthy economies, make for social welfare and sort of civil politics. That's the argument. So he was out there doing all of that. And I was born the year after Intel released its 4004 chip, which is widely regarded as the sort of the chip that kicked off the personal computing revolution. And so, so in the backdrop of people talking about development and development economics and being curious about my own personal story, I was exposed to these ideas. I mean, you don't understand them when you're eight or 10 and you know, but you're exposed to them and you have an affiliation to them and so on. And at the same time, computers were entering into the popular consciousness.Azeem Azhar: You know, you had C-3PO, the robot and computers in Star Trek, and I saw a computer in 1979 and I had one from 1981. And so my interest in these things, these two tracks was start set off quite early on and I really, really loved the computing. And I did, you did notice, but you don't necessarily understand that, why computers are getting more and more powerful. My first computer only had one color. Well, it had two, white and black. And my second could manage 16 at some time, probably not 16. Eight out of a palette of 16 at any given time. And they get better and better. And so alongside my life were computers getting faster. I'm learning to program them and discovering the internet and that, I think, has always sat alongside me against this kind of family curiosity. I suspect if my parents had been, I don't know, doctors, I would have been in your field in the field of bioinformatics and applying exponential technologies to health care. And if my parents had been engineers, I would have been doing something that intersected engineering and computing.Harry Glorikian: Yeah, no, it's you know, it's interesting, I remember when we got our first chip, when I was first learning about, you know, computers like it was, you know, eight bits, right? And then 16 bits and oh my god, what can we do with them? And we were building them, and I actually have to get you a copy of my new book because I think if you read the first chapter and what you just said, you'll be like, Oh my God, we have more in common than we may think, even though you know you're where you are and I'm in the health care field to. But you were co-founder and CEO of a company, I believe that was called PeerIndex, which was a startup in the late 2000s. And even back then, you were trying to quantify people's influence on different social media platforms. And I'm trying to remember like, do I even know what the social media platform was back in 2000? It seems like so long ago, and you successfully sold it to Brandwatch in, like, 2014. What did that experience sort of teach you about, you know, the bigger issues and how technology impacts society and vice versa? Because I have to believe that you know your hands on experience and what you were seeing has to have changed the way that you thought about how fast this was going and what it was going to do.Azeem Azhar: Oh, that is an absolutely fantastic, fantastic question. And. You know, you really get to the heart of all of the different things that you learn as a founder. When we when I started PeerIndex, the idea was really that people were going on to the internet with profiles that they maintained for themselves. So up until that point, apart from people who had been really early on the internet, like you and I who used Usenet and then early web pages for ourselves, no one really had a presence. And these social apps like MySpace and Twitter and LinkedIn and Facebook show up and they start to give people a presence. And we felt that initially there would be a clear problem around trying to discover people because at the time the internet was an open network. You could look at anyone's page on Facebook. There weren't these walled gardens. And we looked down on them. So we thought initially that there would be a an opportunity to build some kind of expertise system where I could say, "Listen, find me something that someone who knows something about, you know, sushi restaurants in Berlin." And it would help me find that person. I could connect their profile and talk to them because it was the really early, naive days before Facebook or LinkedIn had advertising on them. And we could we kind of got the technology to work, but actually the market was moving and we couldn't land that.Azeem Azhar: And so we had to kind of pivot, as you do several times, ultimately, until we became this kind of influence analytics for marketers. But the few things that I learned. So the first one was how quickly new players in a market will go from being open to being closed. So it was 2011 when Facebook started to put the shutters down on its data and become a closed garden. And they realized that the network effect and data is what drove them forward. And the second thing was the speed with which what we did changed. So when we were getting going and doing all of this kind of analytics on Twitter and Facebook. They didn't really have data science teams. In fact, Twitter's first data scientists couldn't get a US visa and ended up helping, working with us for several months. And I think back to the fact that we used five or six different core technologies for our data stores in a seven-year period. And in that time, what we did became so much more powerful. So when we started, we had maybe like 50,000 people in this thing, it was really hard to get it to work. The entire company's resources went on it. At one point we were we had about 100 million people in the data in our dataset, or 100 million profiles in the data.Azeem Azhar: They were all public, by the way. I should say this is all public data and it was just like a search engine in a way. And in order to update the index, we would need to run processes on thousands of computers and it would take a big, big, big servers, right? And it would take a day. Yeah. By the time we sold the company, a couple more iterations of Moore's Law, some improvements in software architecture, we were updating 400 million user profiles in real time on a couple of computers. Yep, so not only do we quadrupled the dataset, we had increased its, sort of decreased its latency. It was pretty much real time and we had reduced the amount of computers we needed by a factor of about 400. And it was a really remarkable evolution. And that gets me to the third lesson. So the second lesson is really all about that pace of change in the power of Moore's law. And then the third lesson was really that my engineers learned by doing. They figured out how to do this themselves. And whereas I was sort of roughly involved in the first design, by the time we got to the fifth iteration this was something of a process that was entirely run by some brilliant young members of the team.Harry Glorikian: Yeah, I mean, you've got to actually cook something to understand how to do it and taste it and understand how it's going to come out. So your new book, The Exponential Age, came out this fall. You know, in the first chapter, you sort of identify two main problems, right? One is how do we perceive technology and then or the way we relate to technology and. Can you describe the two problems as you see them and maybe, maybe even hint a little? I don't want I don't want if people want to buy the book, I want them to buy it, but maybe hint that the solution?Azeem Azhar: Yeah. Well, I mean, there are there are a couple of issues here, right, in the Exponential Age. The first is that technology creates all sorts of new potentials and we live them. We're doing this over Zoom, for example. Right. And there are. But the arrival of new potentials always means that there's an old system that is going to be partially or entirely replaced. And so I describe that process as the exponential gap. It is the gap between the potentials of the new and the way in which most of us live our lives. And the thing is, the reason I say "the way most of us live our lives" is because our lives, even in America, which doesn't like its sort of government, are governed by institutions and by regulations. You know, when you when you start to cook, you wash your hands, right? There's no law. That's just an institution, its common habit. If you have teenage kids like I do, you're battling with the fact that people are meant to talk over dinner, not stare at their phones. In the UK there is an institution that says on a red light traffic signal, you never turn. You wait. It's not like the US where you can do that. Now some of these institutions are codified like our traffic laws, and some are not.Azeem Azhar: There are then more formal institutions of different types like, you know, the Fed or NATO or the Supreme Court. And the purpose of institutions, social, formal, legal, informal is to make life easier to live, right? Right, you don't have to remember to put our pants on. I will read a rule that says, put your pants on before you leave the house. It's like you just put them on and everybody kind of knows it. And there's no law that says you should or shouldn't, right. So they become very valuable. But the thing is that the institutions in general, by their nature, don't adapt to at the speed with which these new technologies do adapt. And even slower moving technologies like the printing press really upended institutions. I mean, Europe went into centuries of war just after the printing press emerged. So, so the central heart of the challenge is, on the one hand, we have these slightly magical technologies that do amazing things, but they somewhat break our institutions and we have to figure out how we get our institutions to adapt better. But there's a second complication to all of this, which is that which is, I think, more one that's about historical context. And that complication is that the way we have talked about technology, especially in the West in the last 40 or 50 years, has been to suggest that technology is deterministic.Azeem Azhar: We're a bit like people in a pre-med, pre-science era who just say the child got the pox and the child died. We say the technology arrived and now we must use it. The iPhone arrived and we must use it. TheFacebook arrived, and we must use it. We've gotten into this worldview that technology is this sort of unceasing deterministic force that arrives from nowhere and that a few men and women in Silicon Valley control, can harness it. We've lost sight of the fact that technology is something that we as members of society, as business people, as innovators, as academics, as parents get to shape because it is something that we build ourselves. And that for me was a second challenge. And what I sought to do in the book, as I was describing, the Exponential Age is not only persuade people that we are in the Exponential Age, but also describe how it confuses our institutions broadly defined and also explain why our response has sometimes been a bit poor. Some a large part of which I think is connected to putting technology on a particular pedestal where we don't ask questions of it. And then hopefully at the end of this, I do give some suggestions.Harry Glorikian: Well, it's interesting, right, I've had the pleasure of giving talks to different policy makers, and I always tell them like, you need to move faster, you need to implement policy. It's good to be a little wrong and then fix it. But don't be so far behind the curve that you, you know, some of these things need corralling otherwise, they do get a lot of, you know, get out of hand. Now in health care, we have almost the opposite. We're trying to break the silos of data so that we can improve health care, improve diagnosis, improve outcomes for patients, find new drugs. Harry Glorikian: So I'm going to, I'm going to pivot there a little bit and sort of dive a little deeper into life sciences and health care, right, which is the focus of the show, right? And in the book, you you say that our age is defined by the emergence of several general-purpose technologies, which I'm totally aligned with, and that they are all advancing exponentially. And you actually say biology is one of them. So first, what are the most dramatic examples in your mind of exponential change in life sciences? And how do you believe they're affecting people's health?Azeem Azhar: Well, I mean, if you got the Moderna or BioNTech vaccination, you're a lucky recipient of that technology and it's affecting people's health because it's putting a little nanobots controlled by Bill Gates in your bloodstream to get you to hand over all your bitcoin to him, is the other side of the problem. But I mean, you know, I mean, more seriously, the Moderna vaccine is an example that I give at the at the end of the book comes about so remarkably quickly by a combination of these exponential technologies. I'm just going to look up the dates. So on the 6th of January 2020, there's a release of the sequence of a coronavirus genome from from a respiratory disease in Wuhan. Yeah, and the the genome is just a string of letters, and it's put on GenBank, which is a bit like an open-source story storage for gene sequences. People started to download it, and synthetic genes were rapidly led to more than 200 different vaccines being developed. Moderna, by February the 7th, had its first vials of its vaccine. That was 31 days after the initial release of the sequence and another six days they finalized the sequence of the vaccine and 25 more days to manufacture it. And within a year of the virus sequence being made public, 24 million people had had one dose of it.Azeem Azhar: Now that's really remarkable because in the old days, by which I mean February 2020, experts were telling us it would take at least 18 months to figure out what a vaccine might even look like, let alone tested and in place. So you see this dramatic time compression. Now what were the aspects at play? So one aspect at play was a declining cost of genome sequencing, which the machines are much cheaper. It's much cheaper to sequence these samples. That means that the entire supply chain of RNA amplifiers and so on a more widely available. This then gets shared on a website that can be run at very few dollars. It can get access to millions of people. The companies who are doing the work are using synthetic genes, which means basically writing out new bases, which is another core technology that's going through an exponential cost decline. And they're using a lot of machine learning and big data in order to explore the phenomenally complex biological space to zero in on potential candidates. So that the whole thing knits together a set of these different technologies in a very, very powerful and quite distributed combination.[musical interlude]Harry Glorikian: Let's pause the conversation for a minute to talk about one small but important thing you can do, to help keep the podcast going. And that's to make it easier for other listeners discover the show by leaving a rating and a review on Apple Podcasts.All you have to do is open the Apple Podcasts app on your smartphone, search for The Harry Glorikian Show, and scroll down to the Ratings & Reviews section. Tap the stars to rate the show, and then tap the link that says Write a Review to leave your comments. It'll only take a minute, but you'll be doing us a huge favor.And one more thing. If you like the interviews we do here on the show I know you'll like my new book, The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer. It's a friendly and accessible tour of all the ways today's information technologies are helping us diagnose diseases faster, treat them more precisely, and create personalized diet and exercise programs to prevent them in the first place.The book is now available in Kindle format. Just go to Amazon and search for The Future You by Harry Glorikian.And now, back to the show.[musical interlude]Harry Glorikian: Let's step back here for just a minute. So I wonder if you have a thesis—from a fundamental technology perspective, what's really driving the exponential technological change, right? Do you think that that, is there a force maybe outside of semiconductors that are driving biology forward? What's your view? I mean, if you took the computational tools away from life sciences and drug developers, would we still see the same rapid advances in that area, and the answer could be no, because I can tell you my thoughts after you tell me yours.Azeem Azhar: Well, we wouldn't see the same advances, but we would still see significant advances and it's hard to unpack one from another. But if you look at the I mean, you worked on the genome sequencing stuff. So you know that there's a lot of interesting aspects to do with the reagents that are used the electrochemistry, the arrays and making little ongoing improvements in those areas. There are also key improvements in the actual kind of automation of the processes between each to each step, and some of those automations are not, they're not kind of generalized robots, soft robots, they are trays that are being moved at the right time from one spot to another, stop on a kind of lab bench. So you'd still see the improvements, but you wouldn't see the same pace that we have seen from computing. And for two reasons. So one is that kind of the core ability to store lots of this data, which runs into the exabytes and then sift through it, is closely connected to storage capacity and computation capability. But also even the CAD package that the person used to redraw the designs for the new laboratory bench to handle the new vials of reagents required a computer. But yes, but you know, so what? What's your understanding as someone who is on the inside and, note to listener, that was a bit cruel because Harry is the expert on this one!Harry Glorikian: And oh no, no, no, no. I, you know, it's interesting, right… I believe that now that information is more readily available, which again drives back to sensors, technology, computation, speed as well as storage is changing what we do. Because the information feeds our ability to generate that next idea. And most of this was really hard to get. I mean, back in the day, I mean, if you know, now I wear a medical device on my on my wrist. I mean, you know this, I look as a as a data storage device, right? Data aggregation device. And this I look at it more as a coach, right? And but the information that it's getting, you know, from me on a momentary basis is, I mean, one of the companies I helped start, I mean, we have trillions of heartbeats, trillions. Can you imagine the analytics from a machine learning and, you know, A.I. perspective that I can do on that to look for? Is there a signal of a disease? Can I see sleep apnea or one of the I could never have done that 10 years ago.Azeem Azhar: I mean, even 10, how about I mean, five maybe, right? I mean, the thing that I find remarkable about about all of this is what it's told me. So I went from I used to check my bloods every year and so I would get a glucose reading or an insulin reading every year. I then put a CGM on continuous glucose monitor and I wore it for 16 to 18 weeks and it gave me a reading every 15 months minutes. So I literally went from once a year, which is 365 times 96, 15 minute intervals. So it's like a 40,000-fold improvement. I went to from to that every 15 minutes, and it was incredible and amazing and changed my life in so many good ways, which I'm happy to go into later. But the moment I put the 15 minute on, I kid you not, within an hour I was looking for the streaming cGMPs that give you real time feed. No 15-minute delay. And there is one that Abbott makes through a company, sells through a company called Super Sapiens. But because suddenly I was like a pilot whose altimeter doesn't just tell them you're in the air or you've hit the ground, which is what happened when I used to go once a year, I've gone to getting an altitude reading every minute, which is great, but still not brilliant for landing the plane to where I could get this every second. And this would be incredible. And I find that really amazing. I just I just and what we can then do with that across longitudinal data is just something else.Harry Glorikian: We're totally aligned. And, you know, jumping back to the deflationary force of all this. Is. What we can do near-patient, what we can do at home, what we can do at, you know, I'll call it CVS, I think by you, it would be Boots. But what these technologies bring to us and how it helps a person manage themselves more accurately or, you know, more insightfully, I think, brings us not to chronic health, but we will be able to keep people healthier, longer and at a much, much lower cost than we did before because. As you know, every time we go to the hospital, it's usually big machines, very expensive, somebody to do the interpretation. And now if we can get that information to the patient themselves and AI and machine learning can make that information easier for them to interpret. They can actually do something actionable that that that makes a difference.Azeem Azhar: I mean, I think it's a really remarkable opportunity with a big caveat that where we can look at look historically, so you know, we're big fans of the Hamilton musical in my household. And if you go back to that time, which is only a couple of hundred years ago and you said to them, this is the kind of magic medicine they'll have in the US by 2020. I mean, it's space tech. It's alien space tech. You know, you can go in and we measure things they didn't even know could be measured, right, like the level of antibodies in the bloodstream. And you can get that done in an hour almost anywhere, right? Yeah. And it's really quite cheap because GDP per capita in the per head in the US is like $60,000 a year. And I can go and get my blood run. A full panel run for $300 in London, one of the most expensive cities in the world. 60 grand a year. $300. Well, surely everybody's getting that done. And yet and you know this better than me. Right. You know this better than me that despite that, we don't have everyone getting their bloods done because it's just so cheap, right, there are other structural things that go on about who gets access, and I think America is a great example of this because for all the people who read, we are aware of Whoop, and have, you know, biological ages that are 10 years younger than their chronological age, you've also got like a much, much larger incidence of deaths by drug overdose and chronic obesity and sort of diseases of inflammation and so on. And that's despite having magical the magical space technology of the 2020s. So the question I think we have to have is why would we feel that next year's optoelectronic sensors from Rockly or the Series 7 or Series 8 Apple Watch will make the blindest bit of difference to health outcomes for the average American.Harry Glorikian: Now, I totally agree with you, I mean, I think half of it is education, communication. You know, there's a lot of social and political and policy and communication issues that exist, and actually that was going to be my next, one of my next questions for you, which is: What are some of the ways that exponential change challenges our existing social and political structures? And you know, do you see any—based on all the people that you've talked to, you know, writing the book, et cetera—insights of how we're going, what those are and maybe some ideas about how we can move beyond them.Azeem Azhar: Hmm. Well, I mean, on the health care side, I think one of the most important issues is and this is I mean, look, you've got an American audience and your health system is very different to, let's just say everyone.Harry Glorikian: Actually, the audience is global. So everybody, I have people that all over the world that listen to this.Azeem Azhar: Fair enough. Okay. Even better, so the rest of the world will understand this point, perhaps more, which is that, you know, in many place parts of the world, health care is treated as not, you know, it's treated differently to I take a vacation or a mutual bond that you buy, right or a car, it's not seen purely as a kind of profit vehicle. It's seen as something that serves the individual and serves a community and public health and so on matters. And I think one of the opportunities that we have is to think out for it, look out for is how do we get the benefits of aggregated health data, which is what you need. You need aggregate population wide data that connects a genotype to a phenotype. In other words, what the gene says to how it gets expressed to me physically to my biomarkers, you know, my, what's in my microbiota, what my blood pressure is on a minute by minute basis and my glucose levels and so on. And to whatever illnesses and diseases and conditions I seem to have, right, the more of that that we have, the more we can build predictive models that allow for the right kind of interventions and pre-habilitation right rather than rehabilitation. But in order to do that at the heart of that, yes, there's some technology. But at the heart of that is how do we get people's data in such a way that they are willing to provide that in a way that is not forced on them through the duress of the state or the duress of our sort of financial servitude? And so that, I think, is something that we really, really need to think about the trouble that we've had as the companies have done really well out of consumer data recently.Azeem Azhar: And I don't just mean Google and Facebook, but even all the marketing companies before that did so through a kind of abusive use of that data where it wasn't really done for our benefit. You know, I used to get a lot of spam letters through my front door. Physical ones. I was never delighted for it, ever. And so I think that one of the things we have to think, think about is how are we going to be able to build common structures that protect our data but still create the opportunities to develop new and novel therapeutic diagnosis, early warning systems? And that's not to say there shouldn't be profit making companies on there that absolutely should be. But the trouble is, the moment that you allow the data resource to be impinged upon, then you either head down this way of kind of the sort of dominance that Facebook has, or you head down away the root of that kind of abuse of spam, junk email and so on, and junk physical mail.Azeem Azhar: So I think there is this one idea that that emerges as an answer, which is the idea of the data commons or the data collective. Yeah. We actually have a couple of them working in health care in in the U.K., roughly. So there's one around CT scans of COVID patients. So there's lots and lots of CT scans and other kind of lung imaging of COVID patients. And that's maintained in a repository, the sort of national COVID lung imaging databank or something. And if you're if you're an approved researcher, you can get access to that and it's done on a non-commercial basis, but you could build something commercially over the top of it. Now the question is why would I give that scan over? Well, I gave give it over because I've been given a cast-iron guarantee about how it's going to be used and how my personal data will be, may or may not be used within that. I would never consider giving that kind of data to a company run by Mark Zuckerberg or, you know, anyone else. And that, I think, is the the cross-over point, which is in order to access this, the benefits of this aggregate data from all these sensors, we need to have a sort of human-centric approach to ensure that the exploitation can happen profitably, but for our benefit in the long run.Harry Glorikian: Yeah, I mean, I'm looking at some interesting encryption technologies where nothing is ever unencrypted, but you can, you know, the algorithm can learn from the data, right? And you're not opening it up. And so there, I believe that there are some solutions that can make give the side that needs the data what they need, but protect the other side. I still think we need to policymakers and regulators to step up. That would cause that shift to happen faster. But you know, I think some of those people that are making those policies don't even understand the phone they're holding in their hands most of the time and the power that they're holding. So. You know, last set of questions is. Do you think it's possible for society to adapt to exponential change and learn how to manage it productively?Azeem Azhar: It's a really hard question. I'm sure we will muddle through. We will muddle through because we're good at muddling through, you know? But the question is, does that muddling through look more like the depression years. Or does that muddling through look like a kind of directed Marshall Plan. Because they both get through. One comes through with sort of more productive, generative vigor? What I hoped to do in the book was to be able to express to a wider audience some underlying understanding about how the technologies work, so they can identify the right questions to to ask. And what I wanted to do for people to work in the technology field is draw some threads together because a lot of this will be familiar to them, but take those threads to their consequences. And in a way, you know, if I if I tell you, Harry, don't think of an elephant. What are you thinking about right  now?Harry Glorikian: Yeah. Yeah, of course it's not, you know, suggestive.Azeem Azhar: And by laying out these things for these different audiences in different ways, I'm hoping that they will remember them and bear those in mind when they go out and think about how they influence the world, whether it's decisions they make from a product they might buy or not buy, or how they talk influence their elected officials or how they steer their corporate strategy or the products they choose to build. I mean, that's what you would you would hope to do. And then hopefully you create a more streamlined approach to it to the change that needs to happen. Now here's the sort of fascinating thing here, is that over the summer of 2021, the Chinese authorities across a wide range of areas went in using a number of different regulators and stamped on a whole set of Exponential Age companies, whether it was online gaming or online education. The big, multi sided social networks, a lot of fintech, a lot of crypto. And they essentially had been observing the experiment to learn, and they had figured out what things didn't align with their perceived obligations as a government to the state and to the people. Now, you know, I'm using that language because I don't want this to become a kind of polarized sort of argument.Azeem Azhar: I'm just saying, here's a state where you may not agree with its objectives and the way it's accountable, but in its own conception, it's accountable to its people and has to look out for their benefit. And it took action on these companies in really, really abrupt ways. And. If you assume that their actions were rational and they were smart people and I've met some of them and they're super smart people, it tells you something about what one group of clever people think is needed at these times. This sort of time. And I'm not I'm not advocating for that kind of response in the US or in Western Europe, but rather than to say, you know, when your next-door neighbor, and you live in an apartment block and your next-door neighbor you don't like much runs out and says the whole building is on fire. The fact that you don't like him shouldn't mean that you should ignore the fact that there's a fire. And I think that some sometimes there is some real value in looking at how other countries are contending with this and trying to understand the rationale for it, because the Chinese were for all the strength of their state, were really struggling with the power of the exponential hedge funds in their in their domain within Europe.Azeem Azhar: The European Union has recognized that these companies, the technologies provide a lot of benefit. But the way the companies are structured has a really challenging impact on the way in which European citizens lives operate, and they are making taking their own moves. And I'll give you a simple example, that the right to repair movement has been a very important one, and there's been a lot of legislative pressure in the in Europe that is that we should be have the right to repair our iPhones and smartphones. And having told us for years it wasn't possible suddenly, Apple in the last few days has announced all these repair kits self-repair kits. So it turns out that what is impossible means may mean what's politically expedient rather than anything else. And so my sense is that that by engaging in the conversation and being more active, we can get ultimately get better outcomes. And we don't have to go the route of China in order to achieve those, which is an incredibly sort of…Harry Glorikian: A draconian way. Yes.Azeem Azhar: Yeah. Very, very draconian. But equally, you can't you know where that where I hear the U.S. debate running around, which is an ultimately about Section 230 of the Communications Decency Act, and not much beyond that, I think is problematic because it's missing a lot of opportunities to sort of write the stuff and foster some amazing innovation and some amazing new businesses in this space.Harry Glorikian: Oh yeah, that's, again, that's why, whenever I get a chance to talk to policymakers, I'm like, “You guys need to get ahead of this because you just don't understand how quickly it's moving and how much it's going to impact what's there, and what's going to happen next.” And if you think about the business model shifts by some of these... I mean, what I always tell people is like, okay, if you can now sequence a whole genome for $50 think about all the new business models and all the new opportunities that will open up versus when it was $1000. It sort of changes the paradigm, but most people don't think that we're going to see that stepwise change. Or, you know, Google was, DeepMind was doing the optical analysis, and they announced, you know, they could do one analysis and everybody was like, Oh, that's great, but it's just one. And a year later, they announced we could do 50. Right? And I'm like, you're not seeing how quickly this is changing, right? One to 50 in 12 months is, that's a huge shift, and if you consider what the next one is going to be, it changes the whole field. It could change the entire field of ophthalmology, especially when you combine it with something like telemedicine. So we could talk for hours about this. I look forward to continuing this conversation. I think that we would, you know, there's a lot of common ground, although you're I'm in health care and you're almost everywhere else.Azeem Azhar: I mean, I have to say that the opportunity in in health care is so global as well because, you know, if you think about how long and how much it costs to train a doctor and you think about the kind of margin that live that sits on current medical devices and how fragile, they might be in certain operating environments and the thought that you could start to do more and more of this with a $40 sensor inside a $250 smartwatch is a really, really appealing and exciting, exciting one. Yeah.Harry Glorikian: Excellent. Well, thank you so much for the time and look forward to staying in touch and I wish you great success with the book and everything else.Azeem Azhar: Thank you so much, Harry. Appreciate it.Harry Glorikian: That's it for this week's episode. You can find past episodes of The Harry Glorikian Show and the MoneyBall Medicine show at my website, glorikian.com, under the tab Podcasts.Don't forget to go to Apple Podcasts to leave a rating and review for the show. You can also find me on Twitter at hglorikian. And we always love it when listeners post about the show there, or on other social media. Thanks for listening, stay healthy, and be sure to tune in two weeks from now for our next interview.

Guerras de Negocios
Guerra de las Vacunas | Largo Plazo | 3

Guerras de Negocios

Play Episode Listen Later Jan 18, 2022 27:52


Es febrero de 2020 y la farmacéutica Moderna arranca en punta – su vacuna contra el Covid ya está lista para comenzar las pruebas en humanos.Pero Moderna y sus rivales saben que muchas vacunas nunca superan la etapa de prueba. También hará falta una gran capacidad de fabricación para inocular al mundo entero. Y todo eso cuesta mcho dinero.Si los fabricantes de vacunas no pueden conseguir un socio inversionista a tiempo, quedarán descalificados de la carrera.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Economist Morning Briefing
The Economist Morning Briefing, January 18th, 2022

The Economist Morning Briefing

Play Episode Listen Later Jan 18, 2022 4:10


Ash hinders relief efforts in Tonga and Moderna plans combined covid-and-flu jab  See acast.com/privacy for privacy and opt-out information.

Medita Podcast
Mindfulness, una práctica milenaria muy moderna, entrevista con el Dr. Eric López. MDT238

Medita Podcast

Play Episode Listen Later Jan 18, 2022 56:32


El día de hoy, el Dr. Eric López, reconocido maestro de Mindfulness, nos cuenta todo lo que tienes que saber acerca de está maravillosa práctica meditativa ¿De dónde viene? ¿Por qué se puso de moda? ¿Cómo empezar a practicarla? Y más.Te invito a escucharla con los oídos y corazón abiertos, estoy segura que será de gran valor en tu gran camino al bienestar.¿Quieres saber más acerca del Dr. Eric López? Te invito a visitar:Su página: www.mindfulness.org.mxSu Facebook: https://www.facebook.com/institutomexicanodemindfulnessGracias por escucharnos y dejarme llegar a tus oídos cada martes con Medita Podcast.Todo acerca de FAMILIA MINDFUL: https://bit.ly/FamiliaMindfulDescarga tu Diario de Gratitud aquí: https://bit.ly/DiarioGratitud21Gracias por escuchar Medita Podcast, recuerda que cualquier duda, idea o propuesta estoy para ti en:IG: www.instagram.com/mardelcerroIG: www.instagram.com/meditapodcastCorreo: mar@mardelcerro.comBonita semana.Namaste, Mar.

Lift the Veil
1/17/2022: SARS-CoV2 Has Code Patented By Moderna, Djokovic Banned Worldwide

Lift the Veil

Play Episode Listen Later Jan 18, 2022 51:08


Truth Revolution Clothing: http://truthclothing.io JJ's CBD Rub: http://jjscbdrub.com Crypto consulting: http://bitcoinmissionary.com Crypto Discord: https://discord.gg/84XW7FPdPq Email: lifttheveil411@gmail.com

American Reveille Podcast
Ep 183 | Everyday Americans Are Sick and Tired of C19 Hysteria so we Follow the Money!

American Reveille Podcast

Play Episode Listen Later Jan 17, 2022 126:48


In episode 183 of the American Reveille Podcast, I show you where the C19 money eventually goes. We talk the 2021 Covid recap, Biden pushing boosters onto children, Biden holding Red states hostage from Covid treatments, and the Pharmaceutical Big Tech Democrat Mass Media Megazord banning Dr. Robert Malone from Twitter while Pfizer quietly denounces cloth masks. So whats this lead us to? Someones hiding something! I follow the money. What do you know? Pfizer, BioNTech, and Moderna make $1,000 every second!!! Tons of executives got rich or richer!!! and Fauci has $10,000,000 dollars invested in Chinese companies?! The people fight back as the Supreme Court strikes down the vax mandate. And I see a light at the end of the tunnel and it sounds like Omicron!SOURCES:https://www.theepochtimes.com/2021-covid-19-recap-200-million-vaccinated-450000-dead_4190440.htmlhttps://www.foxbusiness.com/lifestyle/joe-biden-backlash-fda-process-booster-shots-childrenhttps://www.foxnews.com/politics/ron-desantis-biden-monoclonal-antibodieshttps://www.theepochtimes.com/dr-robert-malone-to-rogan-us-in-mass-formation-psychosis-over-covid_4189087.htmlhttps://www.theepochtimes.com/pfizer-board-member-cloth-masks-dont-provide-much-protection-against-ccp-virus_4190514.htmlhttps://reliefweb.int/report/world/pfizer-biontech-and-moderna-making-1000-profit-every-second-while-world-s-pooresthttps://www.forbes.com/sites/forbesdigitalcovers/2021/05/14/virus-book-excerpt-nina-burleigh-how-the-covid-19-vaccine-injected-billions-into-big-pharma-albert-bourla-moncef-slaoui/?sh=6510e70b7d80https://www.breitbart.com/science/2022/01/15/anthony-faucis-10m-2020-investment-portfolio-chinese-companies/https://www.breitbart.com/politics/2022/01/13/supreme-court-strikes-biden-vaccine-mandate/https://www.wsj.com/articles/omicron-variant-may-end-up-saving-lives-infection-antibodies-spread-sick-covid-19-coronavirus-hospitalization-death-vaccine-11641153969SUPPORT US:Please Help Fund the American Reveille! - http://ow.ly/9ckY50DA5c2Newsletter - http://ow.ly/3ha850DFm0oVIDEO:YouTube - http://ow.ly/enQk50DA5bnRumble - http://ow.ly/BVx550DA573Odysee - http://ow.ly/utOG50DA571GabTV - http://ow.ly/ejBB50EI4ThBitChute - http://ow.ly/6dnU50EI4TiAUDIO:Apple Podcasts - http://ow.ly/Nlsw50zvkUTSpotify - http://ow.ly/gOON50zPya7iHeartRadio - http://ow.ly/Cjbm50EI4TjTuneIn - http://ow.ly/I2Pe50EI4TfDeezer - http://ow.ly/PuHK50EI4UUSOCIAL:Gab - http://ow.ly/w3kq50DA56ZGETTR - http://ow.ly/OSSd50Fp6dXMewe - http://ow.ly/Qqu650EIcjIAR Website - http://ow.ly/eO3g50DA5boInstagram - http://ow.ly/BN7h50DA56Y Facebook - https://www.facebook.com/AmericanReveille

El Bueno, la Mala y el Feo
Mitos y verdades sobre la mezcla en las dosis de vacunación

El Bueno, la Mala y el Feo

Play Episode Listen Later Jan 14, 2022 61:46


Mucha información se viene difundiendo sobre cuál vacuna es mejor y cual no. Pero a la hora de aplicarte la segunda y tercera dosis de diferentes laboratorios surgen infinidad de preguntas que nuestro médico de cabecera Daniel Linares quiere despejar para nuestros oyentes.¿Preferirías trabajar solo 4 días de la semana por menos dinero? Nuestros oyentes opinaron sobre las diferentes opciones laborales para elegir entre tener vida o tener dinero.¿Existen maneras de divertirse gratis? Atención a esta lista para pasarla bien sin  feria con Andrés Gutiérrez  el machete pa tu billete.

NZZ Akzent
Pharma: Das Geschäft mit Corona

NZZ Akzent

Play Episode Listen Later Jan 14, 2022 17:30


Hersteller der Corona-Schutzimpfung sind an der Börse nicht mehr gefragt. Die Aktien der beiden Vakzinhersteller Biontech und Moderna haben gegenüber ihren Höchstkursen die Hälfte an Wert verloren. Das wirft die Frage auf: Wie nachhaltig ist das Geschäft mit Corona? Heutiger Gast: Dominik Feldges Weitere Informationen zum Thema: https://www.nzz.ch/wirtschaft/die-pharmabranche-schwimmt-im-geld-ld.1663810 Hörerinnen und Hörer von «NZZ Akzent» lesen die NZZ online oder in gedruckter Form drei Monate lang zum Preis von einem Monat. Zum Angebot: nzz.ch/akzentabo

Der Tag in Sachsen-Anhalt
Donnerstag, der 13. Januar 2022

Der Tag in Sachsen-Anhalt

Play Episode Listen Later Jan 13, 2022 9:51


Wirtschafts- und Klimaschutzminister Habeck sieht Deutschland bei der Energiewende vor großen Herausforderungen. Mit diesem Thema beginnt der Podcast „Der Tag in Sachsen-Anhalt“. Am Mikrofon ist Marcel Knop-Schieback.

Der Tag in Sachsen-Anhalt
Donnerstag, der 13. Januar 2022

Der Tag in Sachsen-Anhalt

Play Episode Listen Later Jan 13, 2022 9:51


Wirtschafts- und Klimaschutzminister Habeck sieht Deutschland bei der Energiewende vor großen Herausforderungen. Mit diesem Thema beginnt der Podcast „Der Tag in Sachsen-Anhalt“. Am Mikrofon ist Marcel Knop-Schieback.

Democracy Now! Video
Democracy Now! 2022-01-13 Thursday

Democracy Now! Video

Play Episode Listen Later Jan 13, 2022 59:00


Critics warn the 2022 midterms will bring a wave of Republican victories due to voter suppression and election tampering; A self-described "human guinea pig" who volunteered for Moderna's COVID-19 vaccine trials drops out to protest the company's corporate greed; In a new book, The Nation's John Nichols takes aim at the corporations and political figures who put profits over people during the coronavirus pandemic. Get Democracy Now! delivered right to your inbox. Sign up for the Daily Digest: democracynow.org/subscribe

Tom Nikkola Audio Articles
How the Unvaccinated Will Help Uncover the Truth

Tom Nikkola Audio Articles

Play Episode Listen Later Jan 12, 2022 17:25


The truth only matters if you can prove it. And even then, we've seen it doesn't matter if the right people are in power.  But, regardless of what the President or mainstream media say, the truth about the vaccines gets revealed when someone we know gets harmed by them. For many, vaccine injury seems like a conspiracy theory until it hits home. And with the COVID vaccines, they're hitting home unlike any other vaccine in history. To avoid admitting this reality, our politicians (both Trump and Biden alike) and the media gaslight the public, acting as though there's no public health threat from the vaccines, and continuing to vilify the unvaccinated. Many say we're just beginning to see what the vaccines could do to us. Something like myocarditis, one of the most common severe adverse events, takes time to kill people. At 3-5 years, it has a 56-83% survival rate. That means, at best, 17% of people who develop it will be dead five years later. Instead of facing this head on, we're told that the condition is extremely rare and people recover quickly. Yet, that contradicts the scientific evidence. The point is, many are hellbent on hiding the truth and canceling the truth-tellers. Given enough time, the truth will be hard to find unless the unvaccinated remain committed to their choice, even in the face of social and political pressure. The unvaccinated may eventually become the only source of truth when it comes to the health effects of the vaccines. The Control Group's Role in Scientific Evidence Random, controlled trials form the basis of “scientific evidence” that supports or denies the health benefits of a given treatment.  Researchers use RCTs to study drug treatments, diets, supplements, exercise protocols, psychological counseling methodologies, and numerous other methods to improve human health, fitness, or performance.  RCTs require a minimum of two groups: The treatment group: The study participants who get the treatment.The control group: The study participants who either get a placebo when it's appropriate (such as with a drug or supplement) or who carry on their life like normal without the treatment.  In the COVID vaccines clinical trials, the treatment group got injected with the vaccines, and the control group (a.k.a. placebo group) got injected with saline. Being that mRNA vaccine technology has never been used in humans before, it's crucial to be able to identify long-term safety issues. Logically, you'd do so by keeping the control group "the control group" for years, if not decades, to come. That would be the only way to use clinical trial data to identify the long-term safety of the vaccines. On the other hand, if you wanted to avoid the responsibility of long-term safety issues, you'd eliminate the control group early on in your research. That's just what Pfizer and Moderna did. After six months, which was around the time the companies received Emergency Use Authorization approval, they notified the control group participants that they'd received the placebo and offered them the real vaccines. The majority happily accepted the offer. This choice by the vaccine makers eliminated their ability to measure long-term safety data. The decision by the vaccine companies was almost unheard of in scientific research. Of course, they spun their decision as ethically justified, suggesting that the vaccine was so effective that it would be ethically wrong to not offer it to the placebo group. In reality, the vaccines are nowhere near as effective at controlling COVID as we were told. And they do pose a serious risk for both healthy and unhealthy people, even in the short-term. We've yet to find out what they'll do in the long-term. Stephanie Seneff, co-author of the peer-reviewed paper, Worse than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19, recently wrote:

NOQ Report
Dr. Carrie Madej Issues Shocking Warning About Monoclonal Antibodies

NOQ Report

Play Episode Listen Later Jan 12, 2022 61:37


There's an odd disconnect among many who are opposed to the Covid-19 "vaccines." We generally pan the experimental drugs for a wide variety of reasons ranging from the clear health risks and lack of efficacy all the way to many conspiracy theories that the jabs are just tools for depopulation. Some are opposed for religious reasons. Others are opposed out of pure distrust of Big Pharma and their lap dogs in government.Whatever the reason someone has for being a "vaccine skeptic," there are many who then go and embrace the monoclonal antibodies being offered as a safe and effective treatment for Covid-19. This is where the disconnect comes into play because many of the characteristics that make people skeptical of the vaccines are present in the "safe and effective" monoclonal antibodies.On the latest episode of The Midnight Sentinel, I was joined by Dr. Carrie Madej. It was actually quite challenging to isolate an individual topic to highlight in this article because she drops multiple bombshells in the hour-long interview. I chose the monoclonal antibodies topic because it may be the most pressing for those who are currently experiencing or may soon be experiencing the rapidly spreading Omicron variant."Even in the freedom movement, the 'anti-vaxxers,' people are against getting these injections or genetic modification devices, really, but then I see those same people run to get the monoclonal antibodies and I think, 'Oh, you just have no idea,'" she said."First of all, they're brand new, they're experimental, they have very little research on them, okay," she continued. "You're putting something in your body that we don't have research on. However, we know something about it."So, these are called a cocktail. So, what that is, they're taking antibodies from three sources. One is just a 'human source.' What does that mean? Is it somebody from the street? I mean, what is that? Do we know if they're purified? We don't know. Okay, that's one."Number two, they're using aborted fetal cells. When they say they're not, they're lying. They're using a play on words. They're using the HEK line, the human embryotic kidney cell line. It's 293. What that means is it took 293 ... living babies that were born. So they aborted them alive. They're still living with their heart beating. Then they take them to a cold lab and then they kill them there."It took 293 of them to get that cell line. So what they do is they make those lines cancerous so they never stop dividing. They don't want to tell you they're putting cancer cells from an aborted fetus in you so they're going to tell you that it's 'immortalized' — isn't that a nice word. Then they tell you they're cloned. That's what it means. You're taking in an aborted fetus that was killed in a lab and then you had a cancerous cell line from it that's being injected inside of you. Okay, so you've got two sources."Now, the third one is from a human and a mouse genome pushed together inside of a mouse, and the mouse spits out a human kind of an antibody but from a mouse. So this is something called a chimera. A chimera is two creatures pushed together and they're going to be spitting out an antibody."Now, you have to understand, all the genetic material that a human body takes up, whether we eat it, whether we inhale it, we become injected with it... our bodies are amazing. It takes up genetic material to analyze it, sometimes incorporate it inside our genome. It's called epigenetics."Even at this point of the interview, I was having concerns about the monoclonal antibodies based on the information I was hearing. But it was during the next portion of Dr. Madej's answer that I became truly shocked."There's a problem also with the human-mouse antibody cell line," she continued. "It has a trade name called VelocImmune. So, I knew this, I recognized this from years ago when I had a very big practice here in Georgia. I took different cases, complicated, and of course I got cancer patients. Well, many of them were breast cancer patients that were put on a newer chemotherapy agent immunotherapy."And they use this same mouse-human line. It's called VelocImmune, okay. So they took that line and they put this in this chemo-agent. At first, the people looked great. These women were doing wonderfully. 'I feel good. My tumor shrank.'"And then what happened within one to three years? Sometimes five but usually one to three years there was an allergic reaction, they called it, and a woman would come back loaded with cancer. All the organs looked like they had melted together. I couldn't, nor could the radiologist, tell one organ from another. So, it was a fulminant, terrible reaction. This was a failure."They're going to use the same mouse line on people right now. This is horrifying because, although people are only getting one or two of these doses, not many, this can't be good."No, it definitely cannot be good.As a journalist, it behooves me to always get a second opinion, so I asked some of my sources to verify Dr. Madej's claims. They checked out with flying colors. In fact, the HEK293T cell line she referred too were also used to develop the Moderna and AstraZeneca vaccines. Stories I read about the cell line on corporate media sites went out of their way to say they definitely did not come from aborted fetal cells even as they admitted that they originated from "donated" fetal cells. It was actually comical seeing the "play on words" Dr. Madej had mentioned in action.The interview continued to reveal other extremely important information. We even had opportunities to talk about the Bible, a refreshing shift from my normal interviews with other doctors. It was one of my most enjoyable interviews, which is probably why it lasted the full hour.As I've said many times, my preferred regimen is exercise, healthy eating, sunlight, and Dr. Zelenko's Z-Stack protocol (use promo code "Freedom" for a discount, in case you want to join me in taking the nutraceuticals). While we didn't discuss the nutraceuticals specifically, Dr. Madej was all onboard with everything else we're doing to improve our immunity.It isn't often I tell people that they NEED to watch a particular interview, but this is clearly one of those rare instances. Dr. Madej's advice may be life-saving for many.

Rapid Fire
BACK FROM THE BAN: This Is What We Call “Damage Control”

Rapid Fire

Play Episode Listen Later Jan 12, 2022 68:13


Last week we were banned for everything the CDC director and CEO of Pfizer and Moderna are now saying as fact. So fine, I won't say it. Instead, we'll listen to these admissions out of the same mouths of the people who tried to deem this truth as, "misinformation". FOLLOW ME ON: RUMBLE: https://rumble.com/user/Sav_says LOCALS: https://savsays.locals.com/ YOUTUBE: https://www.youtube.com/savsays ODYSEE: https://odysee.com/@SavSays:7?r=7q7r9... TWITTER: https://twitter.com/RapidFire_Pod INSTAGRAM: https://www.instagram.com/savwith1n/   SUPPORT MY WORK: PAYPAL: https://www.paypal.com/paypalme/savsays WEBSITE: https://www.savsaysofficial.com/  

KBS WORLD Radio Korea 24
Korea 24 - 2022.01.11

KBS WORLD Radio Korea 24

Play Episode Listen Later Jan 11, 2022


Korea24 – 2022.01.11. (Tuesday) News Briefing: North Korea fired off another suspected ballistic missile into the East Sea. South Korea’s Joint Chiefs of Staff said that it traveled at a speech of Mach 10 and appeared to be a ‘more advanced missile’ than the one Pyongyang tested last Wednesday. (Eunice Kim) In-Depth News Analysis: North Korea claimed to have successfully launched a “hypersonic” missile last week. South Korea has, however, expressed doubt over those claims, saying it appeared to be a slightly upgraded version of a ballistic missile. For further analysis on the missile and the implications of the latest launches, Ankit Panda, a Stanton Senior Fellow at the Carnegie Endowment for International Peace joins us on the line. Korea Trending with Jung Ye-won: 1. The Jeju District Court has sentenced 7 teenagers to up to 4 years in prison for attempting to blackmail men with underage prostitution. ("불쌍한 척하면 돼" 낄낄 댄 10대…판사는 "천만에" 징역형 줬다) 2. Shin Yu-bin, the rising table tennis star, has been ruled out of the 2022 Asian Games, after she missed the national team qualification match due to an injury. (제2의 신유빈 찾으려 바꾼 룰…신유빈이 막혔다) 3. US biopharmaceutical giants Pfizer and Moderna will be releasing a specific COVID-19 vaccine to combat the omicron variant this year. (3차 접종 필요없다? 화이자 3월에 오미크론 전용 백신 출시한다) Touch Base in Seoul: This week we meet Jinyoung Lee, a journalist in Hawaii telling the stories of the local Korean community through a documentary series, called ‘Words of Wisdom from the Rainbow State’. She joins us via video to tell us why she quit her job to pursue this project and what she learned along the way. Morning Edition Preview with Mark Wilson-Choi: - In tomorrow’s Korea Times, Jon Dunbar writes about “Collective Behavior”, a collaborative dance performance between South Korea and Denmark. - In tomorrow’s Korea Herald, Song Seung-hyun reports on the conspicuous absence of female leads in the top Korean films of 2021.

Me, Myself, and AI
AI in the Supply Chain: Cold Chain Technologies' Ranjeet Banerjee

Me, Myself, and AI

Play Episode Listen Later Jan 11, 2022 33:43


When Ranjeet Banerjee talks about the work his organization, Cold Chain Technologies (CCT), does to transport vaccines and other biologics that must be temperature controlled, he stresses that the company doesn't solely rely on technology. CCT approaches its work by first considering what problems it's trying to solve, developing use cases, and then considering whether a technology solution might be the best way forward. In this episode, we learn how a combination of Ranjeet's background in chemical engineering, his experience working in the health care space, and a holistic approach to leadership and problem-solving enable him to lead CCT to constantly innovate in the supply chain space. Ranjeet also discusses the benefits of a customer-first mindset and shares insights applicable to leaders in industries beyond health care. Read the episode transcript here. Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the coordinating producers are Allison Ryder and Sophie Rüdinger. Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders. Read more about our show and follow along with the series at https://sloanreview.mit.edu/ai. Guest bio: Ranjeet Banerjee is the CEO of Cold Chain Technologies (CCT), a leading global provider of comprehensive thermal assurance solutions for temperature-sensitive drugs, vaccines, and biologics. Under his leadership, CCT is playing a key role in the COVID-19 pandemic response, with both the Moderna and Johnson & Johnson vaccines exclusively using CCT's thermal assurance packaging solutions across the U.S. CCT is also supporting the in-transit cold chain needs for vaccine distribution across the globe. Previously, Banerjee spent 25 years at global medical technology company Becton Dickinson, most recently serving as corporate executive vice president as well as president of the U.S. and Canada regions, with responsibility for more than $6 billion in revenue. Banerjee is a member of the Advisory Board for the CEO Leadership Alliance of Orange County. He earned a bachelor's degree in chemical engineering from the Indian Institute of Technology.

Alles auf Aktien
Substanz reloaded: Die Rückkehr der Value-Aktien

Alles auf Aktien

Play Episode Listen Later Jan 11, 2022 14:28


In der heutigen Folge „Alles auf Aktien“ berichten die Finanzjournalisten Daniel Eckert und Philipp Vetter über die Gewinner und Verlierer der Gesundheitsbranche und einen Krypto-Multi-Milliardär. Außerdem geht es um Fresenius, Fresenius Medical Care, Bayer, Brenntag, HelloFresh, Moderna, ASML, Binance, Coinbase, Bitcoin, Ether, Munich Re, den Xtrackers MSCI World Value (WKN: A1103E) und iShares Edge MSCI Europe Value Factor (WKN: A12DPP). "Alles auf Aktien" ist der tägliche Börsen-Shot aus der WELT-Wirtschaftsredaktion. Die Wirtschafts- und Finanzjournalisten Holger Zschäpitz, Anja Ettel, Philipp Vetter, Daniel Eckert und Nando Sommerfeldt diskutieren im Wechsel über die wichtigsten News an den Märkten und das Finanzthema des Tages. Außerdem gibt es jeden Tag eine Inspiration, die das Leben leichter machen soll. In nur zehn Minuten geht es um alles, was man aktuell über Aktien, ETFs, Fonds und erfolgreiche Geldanlage wissen sollte. Für erfahrene Anleger und Neueinsteiger. Montag bis Freitag, ab 5 Uhr morgens. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++Werbung+++ Hier geht's zur App: Scalable Capital ist der Broker mit Flatrate. Unbegrenzt Aktien traden und alle ETFs kostenlos besparen – für nur 2,99 € im Monat, ohne weitere Kosten. Und jetzt ab aufs Parkett, die Scalable App downloaden und loslegen. Hier geht's zur App: https://bit.ly/3abrHQm

The Chris Salcedo Show
Chris Salcedo Show: Dr Robert Malone

The Chris Salcedo Show

Play Episode Listen Later Jan 10, 2022 8:40


Robert Malone, a medical doctor and an infectious-disease researcher. Recently suggested that the Pfizer and Moderna vaccines might actually make COVID-19 infections worse. See omnystudio.com/listener for privacy information.

EconTalk
Gregory Zuckerman on the Crazy Race to Create the COVID Vaccine

EconTalk

Play Episode Listen Later Jan 10, 2022 82:56


In the race for a COVID vaccine, how did a couple of companies who had never produced a successful vaccine make it to the finish line so quickly? Gregory Zuckerman talks about his book, A Shot to Save the World, with EconTalk's  Russ Roberts about the daring, deranged, and damaged visionaries behind one of science and medicine's great success stories.

Saxo Market Call
Entire US yield curve lifting and geopolitical nerves weighing

Saxo Market Call

Play Episode Listen Later Jan 10, 2022 20:04


Today's slide deck:  https://bit.ly/3JW7bEM   - Today, we look at December US jobs report indicating that the US is more or less at full employment as payrolls growth is anemic, but the unemployment rate continues to drop aggressively and average hourly earnings to rise steeply. The Fed will continue to feel that it is behind the curve and may have to step up more dramatically than the market is currently pricing, with yields now rising all along the yield curve. Elsewhere, we look at crude oil, commodity index rebalancing, softs, struggling vaccine maker Moderna as omicron may point toward a new phase of the pandemic, geopolitical concerns on Ukraine weighing heavily this week, upcoming earnings calendar and more. Today's pod features Peter Garnry on equities, Ole Hansen on commodities and John J. Hardy hosting and on FX. Intro and outro music by AShamaluevMusic

Alles auf Aktien
Das ewige Duell BMW vs. Mercedes und eine Krypto-Kampfansage

Alles auf Aktien

Play Episode Listen Later Jan 10, 2022 15:02


In der heutigen Folge „Alles auf Aktien“ berichten die Finanzjournalisten Daniel Eckert und Philipp Vetter über Wirbel an den Börsen durch die Sektorrotation und Kosovos Krypto-Kampfansage. Außerdem geht es um Deutsche Bank, Commerzbank, Daimler, BMW, Vitesco, Lufthansa, Tui, Sixt, CTS Eventim, Merck KGaAG, Sartorius, Nemetschek, Hello Fresh, Delivery Hero, Bitcoin, Salesforce, Biontech, Moderna, Valneva, Novavax, Blackrock, DWS und Invesco. "Alles auf Aktien" ist der tägliche Börsen-Shot aus der WELT-Wirtschaftsredaktion. Die Wirtschafts- und Finanzjournalisten Holger Zschäpitz, Anja Ettel, Philipp Vetter, Daniel Eckert und Nando Sommerfeldt diskutieren im Wechsel über die wichtigsten News an den Märkten und das Finanzthema des Tages. Außerdem gibt es jeden Tag eine Inspiration, die das Leben leichter machen soll. In nur zehn Minuten geht es um alles, was man aktuell über Aktien, ETFs, Fonds und erfolgreiche Geldanlage wissen sollte. Für erfahrene Anleger und Neueinsteiger. Montag bis Freitag, ab 5 Uhr morgens. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++Werbung+++ Hier geht's zur App: Scalable Capital ist der Broker mit Flatrate. Unbegrenzt Aktien traden und alle ETFs kostenlos besparen – für nur 2,99 € im Monat, ohne weitere Kosten. Und jetzt ab aufs Parkett, die Scalable App downloaden und loslegen. Hier geht's zur App: https://bit.ly/3abrHQm

The Douglas Coleman Show
The Douglas Coleman Show w_ Sally Kirkland

The Douglas Coleman Show

Play Episode Listen Later Jan 10, 2022 15:28


SALLY KIRKLAND -- Academy Award and Golden Globe nominated actress.And a frequent guest on The Howard Stern Show.https://en.wikipedia.org/wiki/Sally_Kirkland She's been suffering from serious health problems ever since March after she got the Moderna vaccine and wants to go public with it. The Douglas Coleman Show now offers audio and video promotional packages for music artists as well as video promotional packages for authors. We also offer advertising. Please see our website for complete details. http://douglascolemanshow.comIf you have a comment about this episode or any other, please click the link below.https://ratethispodcast.com/douglascolemanshow

You Are Here
Moderna CEO Says ANOTHER Booster Needed | Guests: Isabella Riley & John Doyle | 1/7/22

You Are Here

Play Episode Listen Later Jan 8, 2022 132:22


The Moderna CEO now says people may need a fourth COVID shot as efficacy of the boosters is likely to decline. How long until the fifth shot is announced? A federal judge rejected the FDA's request to produce only 500 pages per month of Pfizer's vaccine data. Instead, the judge ordered a release of 55,000 pages per month. Is this a small win for transparency? Or will the FDA find a new way to deny the public access to this vital information? New York City is the first in the nation to implement vaccine mandates on private sector employees. On top of that, New York is now classifying fake vaccine cards as a class A misdemeanor — punishable by up to a year in jail. The COVID cult will do anything to legitimize the craziness they're pushing. Apparently, this also includes postponing the Grammys, which might be a positive because now no one has to watch the Grammys. We're joined in-studio by Isabella Riley, an ambassador for Turning Point USA and political commentator, and John Doyle, host of the “Heck Off Commie” YouTube channel. John Doyle: YouTube -  @John Doyle  Isabella Riley: Twitter - @isabellarileyus Instagram - @isabellarileyusa YouTube -  @Isabella Riley  TikTok - @isabellarileyusa Note: The content of this video does not provide medical advice. Please seek the advice of local health officials for any COVID vaccine questions & concerns. Subscribe to You Are Here YouTube: https://bit.ly/2XNLhQw • Watch MORE You Are Here on BlazeTV: https://bit.ly/38WB2vw • Check out Elijah Schaffer's YouTube channel: https://bit.ly/3C0yWH8 • Check out Sydney Watson's YouTube channel: https://bit.ly/2YIedK5 • Follow Sydney Watson on Twitter: https://twitter.com/SydneyLWatson • Follow Elijah Schaffer on Twitter: https://twitter.com/ElijahSchaffer Learn more about your ad choices. Visit megaphone.fm/adchoices

The Patriotically Correct Radio Show with Stew Peters | #PCRadio
Hackers Reveal DEADLY Jab Lot Numbers, HORRIFIC Pfizer Teen Trial Data and MORE!

The Patriotically Correct Radio Show with Stew Peters | #PCRadio

Play Episode Listen Later Jan 7, 2022 56:03


Dr. Jane Ruby discusses the data about the tainted Covid vaccines which are STILL in circulation throughout the country, putting exponentially more lives at risk. Recently on this show Dr. Jane Ruby came on and gave us the remarkable information that a huge percentage of side effects tracked in the CDC's VAERS database are linked to just a small percentage of the vaccine batches produced by Pfizer and Moderna. This data came from a group calling itself Team Enigma. They're a group of independent researchers with experience in medical R&D, statistics, data analytics, and everything else you'd need to investigate a vaccine's impact on millions of people. A lot of Team Enigma is anonymous but thankfully one of their number has agreed to speak publicly. Sasha Latypova joins us to discuss. Deanna Lorraine discusses the horrifying details about child and teen mortality from the bioweapon clot-shot being forced on minors through propaganda and tyrannical laws. Todd Coconato is a pastor and head of Todd Coconato Ministries based in Nashville, Tennessee. He's also president of the Religious Liberties Coalition, and founder of Remnant News, a Christian news outlet. He's also been a prominent voice against President Biden's federal vaccine mandate.  Get Dr. Zelenko's Anti-Shedding Treatment, NOW AVAILABLE FOR KIDS: http://zStackProtocol.com Go Ad-Free, Get Exclusive Content, Become a Premium user: https://redvoicemedia.com/premium Follow Stew on social media: http://evrl.ink/StewPeters See all of Stew's content at https://StewPeters.TV Watch full episodes here: https://redvoicemedia.net/stew-full-shows Check out Stew's store: http://StewPeters.shop Support our efforts to keep truth alive: https://www.redvoicemedia.com/support-red-voice-media/ Advertise with Red Voice Media: https://redvoicemedia.net/ads

chycho
Ep.112: Covid, Medical Apartheid, Fascism, Censorship, Cryptocurrencies, Investing & more [ASMR]

chycho

Play Episode Listen Later Jan 7, 2022 118:22


Video on BitChute: https://www.bitchute.com/video/7C8GI1n0VcYF/ Video on Rumble: https://rumble.com/vs3ei5-current-events-held-on-dec-30-2021.html Video on Odysee: https://odysee.com/@chycho:6/Current_Events_Dec30_2021_chycho:4 Introduction Segment on CensorTube: https://youtu.be/D9HMhJqarPU ***SUPPORT*** ▶️ Patreon: https://www.patreon.com/chycho ▶️ Paypal: https://www.paypal.me/chycho ▶️ Subscribe Star: https://www.subscribestar.com/chycho ▶️ Streamlabs at: https://streamlabs.com/chycholive ***FORUM*** ▶️ Discord: https://discord.gg/MXmS7B9 APPROXIMATE TIMESTAMPS: - CensorTube Introduction (0:04-6:04) - Random Chit-Chat - Update on Beard Videos (8:15) - Medical Apartheid Is Preventing Me from Going to the Theater: Now We Live History, How Could They Allow Such Things to Happen (9:32-12:02) - NYPD Went Fascist a Long Time Ago: Martin Niemöller's "First They Came" Applied to New York, Apathy & Apartheid (12:33-14:17) - Random Chit-Chat and Kitty Cat Update - Family Has Puts on Moderna (17:29) - Systemic Racism, Words in Law Have Meaning, Used to control Society: Example from History, Brutalizing the LGBTQ Community - Stone Wall Riot (19:10-28:14) - Free Julian Assange #FreeAssange #1(27:22-27:43) - People Are Sick of Western Medical Tyranny: Eat Well, Meditate, Take Care of Your Body, Mind and Spirit (29:03-31:39) - Do You Feel Lucky? Getting Injected or Not, Do Your Research Before Participating in a Pharmaceutical Experiment (32:11-35:520 - How to Fix Corruption in Government, Ending the Revolving Door: Ending Fascism (37:06-41:49) - Prediction for 2022: Chaos! (43:28-44:24) - Random Chit-Chat - Are Cryptocurrencies a way to Decentralize and Democratize the Economy? Bitcoin, Blockchain & Money SHORT (46:56-50:40) - Are Cryptocurrencies a way to Decentralize and Democratize the Economy? Bitcoin, Blockchain & Money LONG (45:56-53:54) - Taxes and Corruption, Working Around Systems: Building Wealth Off Grid, We Are the Tide (53:55-55:28) - Random Chit-Chat - The Problem with Crypto: Same Problem with Linux, Still Too Complicated for the Normies (57:38-59:56) - VR & Metaverse Discussion (1:00:29) - Trusting Elon Musk and Throwing Bill Gates (1:02:21-1:02:37) - Free Julian Assange #FreeAssange #2 (1:03:58-1:04:17) - Random Chit-Chat - Shit Is Shit! (1:05:34-1:05:43) - Social Democracy to Neoliberalism: Monetization of Society, In Desperate Need of Transparency & Accountability (1:05:48-1:11:42) - Random Chit-Chat - The More Centralized the Power, The More Corruption in the System: Solution is Localization, Decentralization, Devolution (1:16:05-1:17:38) - Food Discussion (1:17:39-1:24:44) - Random Chit-Chat, some Food Talk and Some Geopolitics - Some History: Chile 1973, the Story of Víctor Jara (1:28:06-1:30:59) - Ghislaine Maxwell (1:35:30-1:36:52) - F Twitter (1:37:16-1:37:28) - The United States is an Oligarchy: How to Create Equitable Society, Random Lottery for Government (1:38:10-1:40:43) - Will Trump Run Again? The Democrats are Going to Get Annihilated (1:41:56-1:42:59) - More Random Chit-Chat - Free Julian Assange #FreeAssange #3 (1:54:18-1:54:36)

The Steve Gruber Show
Steve Gruber, Fully Vaccinated no longer means getting 2 shots of Pfizer or Moderna, in fact TV doc Tony Fauci says we should stop using that term altogether!

The Steve Gruber Show

Play Episode Listen Later Jan 6, 2022 11:00


ONE— Another blast of harsh winter weather is head for the nations eastern seaboard—as the outgoing Virginia Governor blames drivers for the I-95 pilke-up—   TWO— I warned you about this before mom and dad—and that is—all the time you have been getting those monthly earned income child tax credits—it meant you might owe taxes later—and that nightmare is coming true—   THREE— And as I have been predicting for a long time—Fully Vaccinated—no longer means getting 2 shots of Pfizer or Moderna—in fact TV doc Tony Fauci says we should stop using that term altogether!   That's right there is no such thing anymore as fully vaxxed—and the new term is Up to Date—   Are you Up to Date on your vaccinations? That is the question that will be rolling out for the rest of your life and mine—   For me—I won't be getting a booster shot—first of all—I am not allowed to because I received monoclonal anti-bodies—and second—I have natural immunity now—and therefore why on earth would I get any more shots?   Let's be honest— two shots and a breakthrough illness—means I have a less than one percent chance of ever getting sick from Covid again—at least that is what I read—I mean it could change—BUT for me—I have made my decision and I don't care what kind of threats are sent my way—I will not comply—there will be no more jabs from Pfizer or Moderna—or anyone else— That ship has sailed—   I mean there are people that need it far more than I do—so I say let em have it—because I don't need it—I don't want it—and I am not going to take it—   I am as Big Tony Fauci the Pusher says now—I am up to date—and that is all I need—  

TRENDIFIER with Julian Dorey
#81 - We Left Nothing Off Limits. | Bill Facciolo

TRENDIFIER with Julian Dorey

Play Episode Listen Later Jan 6, 2022 192:43


Bill Facciolo is a Developer, Computer Scientist, and an amateur meteorologist. ***TIMESTAMPS*** 0:00 - Intro; The Divergent Society; Bo Burnham's Special; Unusual Whales and the options market; Everyone's fallibility with power  28:22 - Money is the taboo at the top of the food chain; Why money drives worldview; Motivation vs. De-motivation; Online commentary and pillow punching 40:16 - The thing that is dividing everybody right now; Talking Omicron & Delta; Julian tells a story about the post-election pandemic focus in 2020; The recent changes in Covid policy; Quarantine time reduced, kids and the Pandemic, States vs Federal policy shift, NYT Fat Cells Report; Julian went to LAVO and got the virus 1:02:45 - Candace Owens gets shut down by Trump; Someone check on Alex Jones; The Feynman Technique; Brian Williams mysterious sign off from MSNBC; Bill talks about the power of propaganda 1:26:30 - Jack Dorsey leaves Twitter; Comparing situation at Block to Twitter; Twitter's new hilarious rule 1:41:57 - The Problem with Erasing history; Julian talks about a problem he had with a WW2 Video on TikTok; Safety Culture & The Physical World; Bill and Julian revisit Jonathan Haidt's Book, “The Coddling of the American Mind” 2:04:25 - Moderna's success during the Pandemic; The Amazon / Washington Post Conflict of Interest; The government oversold the public on purpose?; It's like they want people to question everything; China, The CCP, and the Mafia; The Media's role in the Israel / Palestine Conflict; Bill talks about Rome and the fall of Empires 2:23:42 - “Stiffen your upper lip” culture and its opposite; Comparing Jocko Willink and 21 Savage; Toxic Masculinity; How to achieve true equality among men and women; A surprising, sad current trend 2:39:28 - Our threat of a supply chain shutdown with China and life saving drugs; Mutually assured Destruction; Future wars will be cyber 2:59:32 - An uncontrollable-controlled herd; Why government matters; The hypocrisy of the states rights and federal rights political opposites; Julian talks about one thing that bothers him about the show ~ YouTube EPISODES & CLIPS: https://www.youtube.com/channel/UC0A-v_DL-h76F75xik8h03Q  ~ PRIVADO VPN FOR $4.99/Month: https://privadovpn.com/trendifier/#a_aid=Julian   Get $100 Off The Eight Sleep Pod Pro Mattress / Mattress Cover: https://eight-sleep.ioym.net/trendifier  Julian's Instagram: https://www.instagram.com/julianddorey  ~ Beat provided by: https://freebeats.io  Music Produced by White Hot

Alles auf Aktien
Tech-Crash nach Zinsschock – und Japans Superstar-Aktie

Alles auf Aktien

Play Episode Listen Later Jan 6, 2022 14:58


In der heutigen Folge „Alles auf Aktien“ berichten die Finanzjournalisten Daniel Eckert und Nando Sommerfeldt über ein falsches Hähnchen von Beyond Meat, neue mRNA-Fantasie und die “Fantastischen Vier” der Halbleiterbranche. Außerdem geht es um Pfizer und Biontech, AMD, Nvidia, Qualcomm, Apple, Zscaler, Lucid, Atlassian, Adobe Systems, Align, Okta, Moderna, DataDog und Mercadolibre. "Alles auf Aktien" ist der tägliche Börsen-Shot aus der WELT-Wirtschaftsredaktion. Die Wirtschafts- und Finanzjournalisten Holger Zschäpitz, Anja Ettel, Philipp Vetter, Daniel Eckert und Nando Sommerfeldt diskutieren im Wechsel über die wichtigsten News an den Märkten und das Finanzthema des Tages. Außerdem gibt es jeden Tag eine Inspiration, die das Leben leichter machen soll. In nur zehn Minuten geht es um alles, was man aktuell über Aktien, ETFs, Fonds und erfolgreiche Geldanlage wissen sollte. Für erfahrene Anleger und Neueinsteiger. Montag bis Freitag, ab 5 Uhr morgens. Wir freuen uns an Feedback über aaa@welt.de. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem neu bei WELT: Im werktäglichen Podcast „Kick-off Politik - Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. Mehr auf welt.de/kickoff und überall, wo es Podcasts gibt. +++Werbung+++ Hier geht's zur App: Scalable Capital ist der Broker mit Flatrate. Unbegrenzt Aktien traden und alle ETFs kostenlos besparen – für nur 2,99 € im Monat, ohne weitere Kosten. Und jetzt ab aufs Parkett, die Scalable App downloaden und loslegen. Hier geht's zur App: https://bit.ly/3abrHQm

Public Health On Call
414 - The Disappointing State of Global Vaccination for COVID-19

Public Health On Call

Play Episode Listen Later Jan 5, 2022 15:23


In September 2020, President Biden pledged to vaccinate 70% of the world's population by September 2021. More than a year later, however, the US has delivered about 270 million of the 11 billion doses needed to vaccinate the planet. Lawrence Gostin, a Georgetown University professor and public health expert, returns to the podcast to talk with Stephanie Desmon about how things have gone so wrong, why he isn't optimistic about vaccination equity improvements in 2022, and how vaccine manufacturers could be doing so much more to help.

Raise the Line
Healthcare As an Information Service - Dr. Geoffrey Rutledge, Co-Founder and Chief Medical Officer of HealthTap

Raise the Line

Play Episode Listen Later Jan 4, 2022 25:15


“It's astonishing how many health-related questions are asked on Google every day,” observes Dr. Geoffrey Rutledge. “What we set out to do at HealthTap was create a place where people could get trusted answers.” On this episode of Raise the Line, learn about Dr. Rutledge's longstanding interest in the potential of technology to assist in healthcare delivery. Hear how Dr. Rutledge and his team saw early on the opportunity to deliver healthcare through mobile and electronic devices, and followed through to create a pioneering firm in the virtual healthcare space. Tune in to discover HealthTap's unique question-and-answer interface that features physician crowdsourcing and a peer review process, and hear about their virtual primary care clinic, where patients can have a long-term relationship with a doctor of their choice. Plus, learn why Dr. Rutledge believes technology can enable the interactions that are fundamental to the doctor-patient relationship, and why he envisions a huge role for a consistent virtual care platform in the field.

The Situation with Michael Brown
Politicians Start Catering to Voters

The Situation with Michael Brown

Play Episode Listen Later Jan 4, 2022 36:45


Hour 4: Biden didn't realize meat prices rose. Now, he goes after that industry. New York denies testing resources to white people. COVID fades as midterms get closer. Taxpayer money has gone to Pfizer and Moderna, even though Johnson and Johnson has been widely distributed. The FDA fails in its approval review process. Fauci was upset over vaccine competitors.

Presidente AMLO. Conferencias matutinas
Martes 04 enero 2022 Conferencia de prensa matutina #765 - presidente AMLO

Presidente AMLO. Conferencias matutinas

Play Episode Listen Later Jan 4, 2022 127:54


Anunciamos el inicio de la vacunación de refuerzo contra COVID-19 a personal educativo en 16 estados el próximo 8 de enero. Cinco días después se aplicarán dosis en otras 16 entidades. Las y los maestros recibirán la vacuna Moderna. No se suspenderán las clases. Terminando con este sector y el de adultos mayores se protegerá a personas de 50 a 59 años. Hay abasto suficiente. Llamamos a no caer en pánico ante la variante ómicron, que es más contagiosa pero no causa enfermedad grave, y a mantener cuidados. Es fundamental vacunarse.

Incident Report
Science Vs. Advocacy, Omicron, & More (w/ Dr. Peter Attia & Dr. Marty Makary)

Incident Report

Play Episode Listen Later Jan 3, 2022 159:50


Dr. Peter Attia (host of The Drive), Dr. Marty Makary (Johns Hopkins professor) and I team up to try some serious sense-making in the age of Omicron. Full show notes and Peter's podcast The Drive: https://peterattiamd.com/covid-19-current-state-omicron/ Topic list: Comparing omicron to delta and other mutations [4:15] Measuring immunity and protection from severe disease—circulating antibodies, B cells, and T cells [13:15] Policy questions: what is the end game and how does the world go back to 2019? [18:45] A policy-minded framework for viewing COVID and the problem of groupthink [24:00] The difference between science and advocacy [39:00] Natural immunity from COVID after infection [46:00] The unfortunate erosion of trust in science despite impressive progress [57:15] Do the current mandates and policies make sense in light of existing data? [1:02:30] Risks associated with vaccines, and the risk of being labeled an anti-vaxxer when questioning them [1:18:15] Data on incidence of myocarditis after vaccination with the Pfizer and Moderna vaccines [1:26:15] Outstanding questions about myocarditis as a side effect of mRNA vaccination and the benefit of boosters [1:35:00] The risk-reward of boosters and recommendations being ignored by policy makers in the US [1:40:30] Sowing distrust: Lack of honesty and humility from top officials and policy makers [1:43:30] Thoughts on testing: does it make sense to be pushing widespread testing for COVID? [1:52:15] What is the end point to all of this? [1:58:45] Downstream consequences of lockdowns and draconian policy measures [2:05:30] The polarized nature of COVID—tribalism, skeptics, and demonization of ideas [2:10:30] Looking back at past pandemics for perspective and the potential for another pandemic in the future [2:20:00] What parents can do if their kids are subject to unreasonable policies [2:25:00] Voices of reason in this space [2:28:45] Strong convictions, loosely held: the value in questioning your own beliefs [2:32:15]

Meet Me For Coffee
Is the Epstein and Maxwell story connected to COVID?

Meet Me For Coffee

Play Episode Listen Later Jan 3, 2022 35:01


Joined by journalist Memory Hold, who is popular for exposing the truth on Tiktok and Instagram. We weed through the news you see on mainstream media in a truthful conversation about finding truth behind the story of Epstein and his connection to Bill Gates, and Covid. How deeply involved was Jeffrey Epstein with developing Moderna's vaccine? Find out here. **** About Memory Hold https://www.patreon.com/Memoryhold www.instagram.com/memoryhold1 I am a researcher, citizen journalist, and truth seeker compelled to spread the truth as I learn it to those around me. I seek to adjust the perception on what are popularly known as "Conspiracy Theories" by weeding through the nonsense and sticking to verifiable fact, all while broadcasting the methods I use in order to do so. It was four years ago that my awakening process began, and since then I have made it my mission to broadcast my findings, document my awakening, and spread the truth in a positive, optimistic manner to restore dignity to those who believe in ideas that are often written off as crazy. I hope you'll join me on my, and humanity's, quest toward The Truth! #ghislainemaxwell #jeffreyepstein #billgates #moderna #mrna

The Peter Attia Drive
#189 - COVID-19: Current state of affairs, Omicron, and a search for the end game

The Peter Attia Drive

Play Episode Listen Later Jan 3, 2022 165:14


In this episode, Peter sits down with Drs. Marty Makary and Zubin Damania (aka ZDoggMD), both previous guests on The Drive. Marty is a Johns Hopkins professor and public health researcher and ZDoggMD is a UCSF/Stanford trained internist and the founder of Turntable Health. This episode, recorded on December 27, 2021, was in part inspired by some of the shoddy science and even worse messaging coming from top officials regarding COVID-19. In this discussion, Marty and ZDoggMD discuss what is known about the omicron variant, the risks and benefits of vaccines for all age groups, and the taboo subject of natural immunity and the protection it offers against infection and severe disease. Furthermore, they discuss at length the poor messaging coming from our public officials, the justification (and lack thereof) for certain mandates and policies in light of the current evidence, and the problems caused by the highly politicized and polarized nature of the subject. Themes throughout the conversation include the difference between science and advocacy, the messaging which is sowing mistrust in science despite major progress, and a search for what a possible “end” to this situation might look like.  NOTE: Since this episode was recorded over the holiday and published ASAP, this is an audio-only episode with limited show notes.  We discuss: Comparing omicron to delta and other variants [4:15]; Measuring immunity and protection from severe disease—circulating antibodies, B cells, and T cells [13:15]; Policy questions: what is the end game and how does the world go back to 2019? [18:45]; A policy-minded framework for viewing COVID and the problem of groupthink [24:00]; The difference between science and advocacy [39:00]; Natural immunity from COVID after infection [46:00]; The unfortunate erosion of trust in science despite impressive progress [57:15]; Do the current mandates and policies make sense in light of existing data? [1:02:30]; Risks associated with vaccines, and the risk of being labeled an anti-vaxxer when questioning them [1:18:15]; Data on incidence of myocarditis after vaccination with the Pfizer and Moderna vaccines [1:26:15]; Outstanding questions about myocarditis as a side effect of mRNA vaccination and the benefit of boosters [1:35:00]; The risk-reward of boosters and recommendations being ignored by policy makers in the US [1:40:30]; Sowing distrust: lack of honesty and humility from top officials and policy makers [1:43:30]; Thoughts on testing: does it make sense to push widespread testing for COVID? [1:52:15]; What is the endpoint to all of this? [1:58:45]; Downstream consequences of lockdowns and draconian policy measures [2:05:30]; The polarized nature of COVID—tribalism, skeptics, and demonization of ideas [2:10:30]; Looking back at past pandemics for perspective and the potential for another pandemic in the future [2:20:00]; What parents can do if their kids are subject to unreasonable policies [2:25:00]; Voices of reason in this space [2:28:45]; Strong convictions, loosely held: the value in questioning your own beliefs [2:32:15]; More.   View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Learn More About Peter Attia Sign Up to Receive Peter's Weekly Newsletter Connect With Peter on Twitter, Instagram, Facebook & YouTube

SpaceTime with Stuart Gary | Astronomy, Space & Science News
The Biggest Scientific Discovery of the Past Year

SpaceTime with Stuart Gary | Astronomy, Space & Science News

Play Episode Listen Later Jan 3, 2022 41:55


The Astronomy, Technology, and Space Science News Podcast.SpaceTime Series 25 Episode 1*The biggest scientific discovery of the past year - first black hole-neutron star mergersOne of the unquestionable highlights of the past year in scientific research was the historic confirmation that one of the densest objects in the universe – a neutron star had been consumed by a black hole – the only thing even denser.*Discovery of a huge new population of free-floating planetsAstronomers have discovered at least seventy free floating planets – worlds not orbiting host stars – in our part of the galaxy.*Iran continues its nuclear weapons campaignIran has moved a step closer to developing a nuclear weapon and the means to deliver it with the launch of another missile in what military experts are describing as a thinly disguised rocket launch.*New Dragon docks to the space stationThe SpaceX CRS-24 cargo ship has successfully docked with the International Space Station 418 kilometres over the South Pacific Ocean.*China ends 2021 with more than fifty orbital missionsChina has ended the year 2021 with a flurry of rocket launches as it continues what Beijing describes as preparations for war.*The Science ReportNew studies claim Moderna is slightly more effective at preventing COVID-19 infection.Pollutants in the air linked to changes to the sex ratio of births.Australia to replace its troubled Taipan helicopters with more Blackhawks.An ancient synagogue older than Christianity and Islam, discovered in Galilee.Skeptic's guide to bogus allergy testsListen to SpaceTime on your favorite App with our universal listen link: https://link.chtbl.com/spacetime For more SpaceTime and show links: https://linktr.ee/biteszHQ If you love this podcast, please get someone else to listen too. Thank you…To become a SpaceTime supporter and unlock commercial free editions of the show, gain early access and bonus content, please visit https://bitesz.supercast.com/ . Premium version now available via Spotify and Apple Podcasts.

Unexplainable
BONUS: The 2021 song

Unexplainable

Play Episode Listen Later Dec 31, 2021 5:12


Noam wrote an end-of-year song with Today, Explained host Sean Rameswaram, so we thought to drop it here as a little end-of-year surprise. Lyrics: 2021, it was gonna be fun Get a couple shots and then you're done Then the second the year'd begun We had an insurrection 2021, it was gonna be fun Get a couple shots and then you're done Then the second the year'd begun We had an insurrection Yeah it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible Yeah it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible Dial back to when the year had begun We were looking forward to the end of hibernation  But it didn't even last a week No it didn't even last a week, mm-hmm On the sixth day of 2021 Vanilla Isis tried to flip the election But looking back we can't agree  On the facts, no, we can't agree, mm-mm Pretty soon we were signing up for shots (shots!) Talking about shots (shots!) Shots shots shots (shots!) Everyone was a pharma fan With the Pfizer fam, the Moderna clan (J&J) But we should have known Delta would happen  Most of humanity not getting vaxxed and Fourth wave — fifth wave, in rhythm That's one more wave than feminism! 2021, it was gonna be fun Get a couple shots and then you're done But according to Joe Ro-gun You should take Ivermectin Yeah it wasn't just what we hoped to see We might have started too optimistically But if we keep our expectations low Maybe the world won't seem so terrible A booster, I'm not sure I need it.  Dune on the IMAX, I seen it. Back to the good life, I dreamed it. (Arrakis) Wake up, reality, don't fit. Hope you don't need a house or a condo (a condo) Hope you don't need a trip to Toronto (Toronto) Hope you don't need some gas for your Durango (Durango)  Hope you don't need a can of dried mangos (dried mangos) Everyone is feeling frustration Quitting jobs — the Great Resignation Blaming Biden for rising inflation While billionaires shoot off to space, racing Did we fix the grid in Texas? (yes) Figure out how wide the Suez is? (yes) Don't ask me All I see on TV  It's just fights on Critical Race Theory 2021, it was gonna be fun Get a couple shots and then you're done Moving onto issue number one: Whether to allow abortions! Yeah it wasn't just what we hoped to see We might have started too optimistically But if we keep our expectations low Maybe the world won't seem so terrible I just want to be free Of thinking about Covid-19 I just want to see Something done about global warming And I still don't get NFT's Can't understand crypto currency and And we can't agree on anything But at least we got together to free Britney (Oh baby baby) 2021, it was gonna be fun Get a couple shots and then you're done Then the second as the year'd begun We had an insurrection And people lied about the last election And made it harder to vote in elections At least we don't have another election Wait, I think there's another election... 2021, it was gonna be fun Get a couple shots and then you're done Then the second we thought we'd won We're learning how to say "Omicron" Guess you never know what's gonna come through Making plans for things you'll never do  But take it from a brown guy (and a Jew) There's always 2022. This song was written and performed by Sean Rameswaram and Noam Hassenfeld, produced by Noam, engineered by Efim Shapiro, and features additional vocals from Christina Animashaun. For more, go to http://vox.com/unexplainable It's a great place to view show transcripts and read more about the topics on our show. Also, email us! unexplainable@vox.com We read every email. Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today, Explained

2021, it was gonna be fun Get a couple shots and then you're done Then the second the year'd begun We had an insurrection 2021, it was gonna be fun Get a couple shots and then you're done Then the second the year'd begun We had an insurrection Yeah, it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible Yeah, it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible Dial back to when the year had begun We were looking forward to the end of hibernation But it didn't even last a week No, it didn't even last a week, mm-hmm On the sixth day of 2021 Vanilla Isis tried to flip the election But looking back we can't agree  On the facts, no, we can't agree, mm-mm Pretty soon we were signing up for shots (Shots!) Talking about shots (Shots!) Shots, shots, shots (Shots!) Everyone was a pharma fan With the Pfizer fam, the Moderna clan (J&J) But we should have known Delta would happen  Most of humanity not getting vaxxed and Fourth wave — fifth wave, in rhythm That's one more wave than feminism! (Woo!) 2021, it was gonna be fun Get a couple shots and then you're done But according to Joe Rogan You should take Ivermectin Yeah, it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible A booster, I'm not sure I need it Dune on the IMAX, I seen it Back to the good life, I dreamed it (Arrakis) Wake up, reality, don't fit Hope you don't need a house or a condo (a condo) Hope you don't need a trip to Toronto (Toronto) Hope you don't need some gas for your Durango (Durango) Hope you don't need a can of dried mangos (dried mangos) Everyone is feeling frustration Quitting jobs — the Great Resignation Blaming Biden for rising inflation While billionaires shoot off to space, racing Did we fix the grid in Texas? (Yes!) Figure out how wide the Suez is? (Yes!) Don't ask me, all I see on TV  It's just fights on Critical Race Theory 2021, it was gonna be fun Get a couple shots and then you're done Moving onto issue number one: Whether to allow abortions Yeah, it wasn't just what we hoped to see We might have started too optimistically So if we keep our expectations low Maybe the world won't seem so terrible I just want to be free (I just want to be free) Of thinking about Covid-19 And I just want to see (I just want to see) Something done about global warming And I still don't get NFT's (Don't get NFTs) Can't understand crypto currency  And we can't agree on anything (No, we can't agree) But at least we got together to free Britney (Oh, baby, baby) 2021, it was gonna be fun Get a couple shots and then you're done Then the second as the year'd begun We had an insurrection And people lied about the last election And made it harder to vote in elections At least we don't have another election Wait, I think there's another election... 2021, it was gonna be fun Get a couple shots and then you're done Then the second we thought we'd won We're learning how to say “omicron” Guess you never know what's gonna come through Making plans for things you'll never do  But take it from a brown guy (and a Jew) There's always 2022. This song was written and performed by Sean Rameswaram and Noam Hassenfeld, produced by Noam, engineered by Efim Shapiro, and features additional vocals from Christina Animashaun. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Marketplace All-in-One
In California, a blueprint for addressing the opioid crisis

Marketplace All-in-One

Play Episode Listen Later Dec 28, 2021 26:24


The pandemic has exacerbated the country's opioid crisis. More than 100,000 people in the United States died from drug overdoses last year in the highest one-year death toll on record. Today, we take a look at a recently expanded program in California, one that utilizes medically assisted treatment in emergency rooms and is becoming a model for other programs around the nation. We’ll also hear about the questions Moderna’s shareholders are raising regarding global vaccine equity, take a look at the future of streaming services and examine Brexit’s impact on the United Kingdom’s role as a hub for plundered antiquities.

Marketplace with Kai Ryssdal
In California, a blueprint for addressing the opioid crisis

Marketplace with Kai Ryssdal

Play Episode Listen Later Dec 28, 2021 26:24


The pandemic has exacerbated the country's opioid crisis. More than 100,000 people in the United States died from drug overdoses last year in the highest one-year death toll on record. Today, we take a look at a recently expanded program in California, one that utilizes medically assisted treatment in emergency rooms and is becoming a model for other programs around the nation. We’ll also hear about the questions Moderna’s shareholders are raising regarding global vaccine equity, take a look at the future of streaming services and examine Brexit’s impact on the United Kingdom’s role as a hub for plundered antiquities.

Democracy Now! Audio
Democracy Now! 2021-12-23 Thursday

Democracy Now! Audio

Play Episode Listen Later Dec 23, 2021 59:00


Oxfam leads a shareholder complaint against Moderna for its lack of transparency in a dispute over vaccine patent rights; How the Koch network funneled dark money into right-wing resistance against public health measures during the pandemic; Victory for Kellogg's workers who have ended their strike after receiving a new contract with improved wages and benefits; The Pentagon announces new rules to slow the spread of white supremacist extremism in the military. Get Democracy Now! delivered right to your inbox. Sign up for the Daily Digest: democracynow.org/subscribe